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Cigarette

smoking is the most important health issue of

our time and the most preventable
death.

M.Ed.

Chronic obstructive

frequent consequence

cause of disease and

pulmonary disease

(COPD)

is a

of chronic cigarette smoke exposure.

Patients with COPD who have not stopped smoking earlier in
the course of their disease

are particularly

refractory

to

current smoking interventions.

Most of the current smoking

cessation

for an asymptomatic,

programs are designed

non-diseased

population

and report moderate

results at best.

Recent studies suggest the idea of individualizing
and tailoring

smoking cessation

This study investigated

treatment

therapies to each smoker.

three smoking cessation

therapies

in

two groups of smokers in an attempt to define which therapy
was best for different

types of smokers.

Thirty asymptomatic

cigarette

smokers with COPD were randomized

into one of three smoking

cessation

treatments:

therapy.

The treatment period was for four weeks and was

guided by the American

Individual,

smokers and thirty

Group,

or Self-help

Cancer Society's FreshStart

program.

Smoking

abstinence

was verified

by exhaled

carbon monoxide

levels.
Using carbon monoxide,
variance

was performed.

significantly
Individual
different

lower post-treatment

for number of cigarettes
smoked were significantly
and normal

levels were

for all subjects.

group overall.

analysis

of variance

smoked.

Mean number of cigarettes

lower post-treatment

analysis

restlessness

smoked.

expense of intensive

to significantly

success.

anxiety

and

justify the program

treatments

therapy.

Normal

such as Individual
smokers were able

reduce the number of cigarettes

the COPD group but otherwise

The

in both carbon monoxide

These results

cessation

and Group over Self-help

increased

tobacco

smokers group.

there were decreases

and cigarettes

and

variables,

failed to predict

significantly

over the normal

Overall,

for all

Chi-square

using demographic

and self-efficacy

COPD group reported

was performed

smokers were able to reduce their

more than the COPD group.

discriminant
dependency

of

and Group therapy were found to be significantly
than the Self-help

cigarettes

analysis

Mean carbon monoxide

The same split-plot

subjects

a split-plot

grouping

to be significant.

Further

research

and individualizing

smoking

cessation

smoked over

effects were not found
characterizing
therapy

smokers

is needed.
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CHAPTER ONE

INTRODUCTION

overview

of the Health

Problem

There have been dramatic
of Americans
century,

over the past century.

the leading

pneumonia,

influenza,

infections

Program,

1986).

stroke and chronic

Throughout
health.

(Nebraska Health

obstructive

The cumulative

of medical

Health Education

preventable

and Welfare,

important
scientific

evidence

decisions

has

Department

of

1979).

since the Surgeon
is our greatest
death

(U.S.

In 1986, a second most

report appeared.

to condemn

environmental

our

of life than all

People,

and premature

1964).

surgeon General's

most important

Healthy

all doubt that smoking

Service,

heart disease,

comprise

(U.S.

of a century

cause of disease

Public Health

causes of

impact of lifestyle

care combined

It has been a quarter
dispelled

Education/Risk

that affect our

effect on the length and quality

the efforts

such as

lung disease.

The sum total of these decisions

a greater

General

coronary

of the

and

Today, the leading

life, we make many decisions

lifestyle.

status

At the beginning

tuberculosis

death are in part, self-inflicted:
cancer,

in the health

causes of death were infections

diphtheria,

gastrointestinal
Reduction

changes

cigarette

hazards.

It included

smoke as one of our

The report showed
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that tobacco
smokers,

was a serious threat not only to the lives of

but to their nonsmoking

co-workers

(U.S.

Department

spouses,

children

and

of Health and Human Services,

1986).
Indeed,
most

cigarette

important

Department
1987).

smoking has been proclaimed

public health

of Health

and Human Services,

The Royal College

concluded

that cigarette

single remaining

and encouragement

motivated

1965

even though they are well

Nonetheless,

of Health

just under

33 percent

in 1983

from 42 percent

and Human Services,

(National Center

of
in

1982) to

for Health

1984) the total number of smokers has remained

almost constant.
males declined

(U.S.

is

while the percent

States has declined

Department

General's

efforts to provide

to smokers to stop, many people

(U.S.

statistics,

the largest

agrees that the use of tobacco

to one's health.
in the United

recently

1984).

Just about everyone

smokers

in London

and Health,

cause of death and disease.

quitting

(Hjalmarson,

(U.S.

Smoking

smoking constitutes

public health

have great difficulty

damaging

of Physicians

preventable

Despite widespread
education

issue of our time

to be the

The overall prevalence

dramatically

report

Department

of smoking

after the first U.S. Surgeon

on smoking and health was issued
of Health and Human Services,

decline

has continued

decline

has diminished.

among

among males,

in 1964

1988).

This

but the speed of the

In some categories,

such as for
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women between 20 and 34 years, the percent of smokers
increased from 1980 to 1983 (National Center for Health
Statistics, 1984).

Lung cancer now exceeds breast cancer in

American females (U.S. Department of Health and Human
Services (Smoking in the United States, 1986).
Health Consequences of Smoking
With the exception of the tobacco industry, few would
dispute the connection between cigarette smoking and
preventable morbidity and premature mortality (U.S.
Department of Health, Education and Welfare, Smoking and
Health, 1979).

It has been estimated that there are more

than 50,000 studies linking cigarette smoking to increased
morbidity and mortality from cardiovascular diseases,
various forms of cancer and chronic obstructive lung
diseases (U.S. Department of Health and Human Services, The
Health Consequences of Smoking, 1985).

For example, there

is epidemiologic evidence linking smoking with coronary
heart disease, lung cancer, emphysema, laryngeal and
esophageal cancers, cancer of the bladder, and several
gastrointestinal diseases (e.g., peptic and duodenal ulcers)
(Fielding, 1985).
Each year, 340,000 persons die prematurely from
smoking-related illnesses.

The Surgeon General has stated

that unless smoking habits change, 1 in every 10 people
living today could die prematurely of heart disease alone
(U.S. Department of Health and Human Services, 1983).

In
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addition to smoking's contribution to heart disease, it is
estimated that 30 percent of all cancers are caused by
smoking and that 85 percent of all lung cancers are due to
cigarette smoking (U.S. Department of Health, Education and
Welfare, 1982).
Chronic obstructive pulmonary disease (COPD) is a
frequent consequence of chronic cigarette smoke exposure.
COPD refers specifically to obstructive lung disease such as
chronic bronchitis and emphysema.

The American Thoracic

society's definition of chronic bronchitis is the presence
of a chronic, productive cough for at least three months of
the year for the last two years {U.S. Department of Health
and Human Services, smoking and Health, 1987).

Examination

of COPD mortality rates for smokers and non-smokers suggest
that 85-90 % of deaths due to obstructive lung disease can
be attributed to cigarette smoking (U.S. Department of
Health and Human Services, 1984).

In general, cigarette

smokers have a 70% greater death rate from all causes than
non-smokers (U.S. Department of Health and Human Services,
Smoking and Health, 1987).
Economic Consequences of Smoking
The health consequences and medical costs associated
with cigarette smoking have been established undeniably.
Not only are cigarette smokers at markedly increased risk of
morbidity and mortality, chronic obstructive pulmonary
disease accounts for a sizeable amount of disability in the
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labor force

(U.S.

Department

1985). The costs to society
disabled

also has a costly

billion

dollars

productivity

smoking-related

for medical

In addition,

(U.S.

to lung
Forty two
care and lost

each individual

Department
Guide,

of Health

health

costs could be reduced.

and economically

problem

While numerous

burden

for

unproductive.

If

medical

techniques

have been

of life for patients

there has been growing

is a prevalent

to prevent

were controlled,

to improve the quality

and Human

1985).

than carry the economic

those who become disabled

lung disease,

secondary

it seems less expensive

disease

this particular

and their dependents

for one year save about $837.23 due to

A Decision Makers

As a society,

wage-earners

impact on society.

due to smoking.

the cost of cigarettes

developed

deaths

is spent annually

who is a non-smoker

Services,

disease

Premature

disease

and Human Services,

of supporting

from smoking-related

can be exorbitant.

smoking

of Health

realization

and costly public problem,

with

that while
it is also

preventable.
Declining

Social Acceptability

A great social movement

of Smoking
has taken root to rid America

of its tobacco use.

The social acceptability

smoking

has declined

in the last two decades.

continue

to promote

against

smoking.

nonsmoking

a strongly

developing

of cigarette
Efforts

social climate

Smokers who smoke in the presence

friends increasingly

still

of their

feel as though they are a
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"dragon."

Much attention has been given to the airline

industry regarding the recent smoking ban for passengers and
support personnel on all commercial flights.

Furthermore,

smoke-filled environments are being established in an
increasing number of public buildings.

By 1979, almost half

of all U.S. businesses had a policy restricting or
prohibiting smoking (Windsor & Bartlett, 1984).
Smoking and the Health-Illness Continuum
Countless public education programs have attempted to
promote effective self-regulation of illness threats, such
as smoking, however, people continue to engage in behaviors
which are dangerous to their health (Leventhal, Safer,
Panagis, 1983).

Because so many of the illnesses today are

in part self-inflicted, the prevention and treatment of
these illnesses involve the modification and control of
behavior.
It is important to consider health as separate from
illness.

Many people define illness as ill health and

health as lack of illness.

Greenberg (1985) suggests that

there is a health-illness continuum and that there are many
behavioral dimensions of health and illness.

Kasl (1974)

suggests the major reason for distinguishing "health" and
"illness" is because different sets of determinants are
needed to understand them.

Health behavior takes place in

the absence of symptoms and forms the direction of primary
health education programs.

Illness behavior on the other
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hand, takes place in the presence of symptoms and may
sometimes be compelling enough to provide all the motivation
a person may need.

With regard to smoking, some smokers are

healthy and have no symptomatic complaints (normal smokers),
while other smokers complain of a chronic, productive cough
(COPD).
The Role of Self-efficacy
While it seems that we have little control over health
and illness, much of the recent smoking cessation literature
(Baer, Holt & Lichtenstein, 1986; Best & Hakstian, 1978;
Condiotte & Lichtenstein, 1981; Yates & Thain, 1985)
discusses the role of self-efficacy in a person's ability to
control their own behavior.

Albert Bandura (1969, 1977a,

1977b, 1982, 1986) describes perceived self-efficacy as an
individual's perception of the likelihood that they would be
able to perform a specific behavior in a given situation.
Self-efficacy affects what activities a person chooses to
pursue, how much effort will be mobilized in a given
endeavor, how long one will persevere in the face of
difficulty, and the amount of stress that is experienced.
Clinical experience suggests that self-efficacy plays a role
in the motivation to enroll and persist in a behavior change
program.
The Role of Tobacco Dependency
Tobacco dependency seems to surface as an important
predictor of outcome in smoking cessation programs
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(Fagerstrom, 1978).

Twenty-seven percent of all smokers are

considered heavy smokers in that they smoke 25 or more
cigarettes a day (National Center for Health Statistics,
1985).

Heavy smokers are three to four times more likely to

die of cancer than non-smokers (U.S. Department of Health,
Education and Welfare, 1979).

Heavy smokers who have a

greater dependence on nicotine offer a major challenge to
smoking cessation.
current Trends Toward Smoking Cessation
Since cigarette smoking has been recognized by the
Surgeon General as the most preventable cause of disease in
the United States, many Americans have quit smoking and many
more smokers are eager to quit.

In 1966, just 26 percent of

smokers said they were trying to quit; 16 years later, the
figure had risen to 37 percent (U.S. Department of Health
and Human Services, Smoking and Health, 1983).

The

proportion of individuals who have never smoked also has
risen, although more slowly, from almost 28 percent in 1960
to almost 32 percent in 1980 (U.S. Department of Health and
Human Services, Smoking and Health, 1983).

Yet, there are

many smokers whose common denominator is their inability to
stop smoking on their own.

Cigarette smoking is an

extremely complex and highly refractory behavior.

In spite

of the enormous scientific efforts during recent decades,
the clinician's armamentum in smoking cessation has not
improved all that much.
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Despite knowledge of the health consequences of
cigarette smoking, approximately one third of adults in the
United States continue to smoke (Remington, Forman, Gentry,
Marks, Trowbridge, 1985).

Smoking cessation efforts are

impeded because many of the advantages of continuing smoking
are immediate, whereas the disadvantages of smoking are
delayed (Klesges et al. 1988).
Research programs designed to reduce cigarette smoking
have increased dramatically in the last two decades.

Most

programs continue to be designed for the asymptomatic
non-diseased smoker.

The most recent reviews suggest more

promising results, particularly from multi-component
behaviorally oriented treatment programs (Glasgow &
Bernstein, 1981; Pechacek, 1979).
Only a small number of smoking cessation studies have
been reported in which smokers with chronic disease are the
target population (Sirota, Currlan, Habif, 1985).

Although

it has been reported that many smokers with cardiac and
pulmonary disease quit smoking when given medical advice
(Pederson & Baskerville, 1983), those that do not represent
a particularly difficult group to treat (Hall, Bachman,
Henderson, Barstow & Jones, 1983).

Quitting smoking for

this segment of the population is crucial.

A sizeable

proportion of patients with diagnosed lung disease continue
to smoke despite warnings from physicians.

Long-term

results of treatments for chronic cigarette smoking have
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generally been discouraging (Hunt & Bespalec, 1974;
Lichtenstein & Danaher, 1976).

Patients with underlying

chronic obstructive pulmonary disease, who have not stopped
smoking earlier in the course of their disease, may be
particularly refractory to current smoking interventions.
Disappointing smoking cessation results for these
recalcitrant smokers demonstrates the need for the
investigation of different smoking cessation approaches. It
is clear that smokers exhibit a high degree of individual
difference.

Perhaps smokers need to be further

characterized and smoking cessation therapy conditions
individually tailored.
Need For Individualizing Treatment
Cigarette smoking is a complicated behavior and highly
individualized.

Each individual who smokes does so for

their own reasons and supports their behavior with
underlying personality characteristics.

Little research has

been done on analysis of those personality characteristics
predictive of treatment success or failure.

Decisions

regarding which components to use in treatment programs for
individual subjects are still based on clinical intuition
rather than empirical findings (Pomerleau, Adkins,
Pertschuk, 1978).

Pomerleau et al. (1978) also suggested

that smoking cessation results might be enhanced by
providing components which take into account individual
subject characteristics.

Their objective was to demonstrate
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the role of personality

characteristics

outcome in smoking cessation
empirically-based

in determining

and to demonstrate

suggestions

for individualizing

treatment.
With rising medical costs, we need to develop a clear
understanding
1979).

of the "person-intervention-fit"

An individualized

make intervention

smoking cessation program can help

more cost-effective

whether certain individuals
interventions

(Pechacek,

and can help to decide

need more intensive

while others would do just as well with

minimal contact.
care providers

As with any medication

regimen,

health

should tailor smoking control strategies

to

the individual.
Purpose of the Study
This research was designed to investigate
would be a difference

in mean exhaled carbon monoxide

and mean number of cigarettes
groups of smokers.
manipulated
(COPD)

whether there
levels

smoked for two randomized

smoking cessation therapy was

in smokers with a chronic,

and those who were asymptomatic

productive

cough

(normal).

Individual

therapy was compared with group therapy and these were
compared to self-help therapy.

The main purpose of this

study was an attempt to define the smoking cessation therapy
that worked best for each of these two groups.
information

gained from this research,

educating different

types of smokers

With the

it was hoped that
(those with and without
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lung disease) about the smoking cessation therapy that may
work best for them would lead to the most optimal voluntary
behavior changes.

Other purposes included describing the

relationship between demographic information and smoking
cessation outcome.
This smoking cessation program provided the opportunity
to look at 1) process (a better definition of smoking
cessation therapies in different types of smokers), 2)
impact (smoking cessation) and 3) outcome (prevent further
progression of COPD and increase quality of life).

It also

focused on a more tailored smoking cessation program for
smokers with individual variances.

It was hoped that this

study may be used to show that an individually-tailored
smoking cessation paradigm can be effective in any
clinic-based practice setting for different types of
smokers.

Practical implications to support this study

include the ability to predict successful smoking cessation
attempts in patients with lung disease based on their
self-efficacy and tobacco dependency.

Equally important, an

assessment of the most effective behavior modification
approach for each of these two groups of smokers was
investigated.
Assumption of the Study
The assumption for this study was that smoking
cessation effectiveness depends on further characterization
of smokers.

For example, it was assumed that smokers with
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COPD, higher tobacco dependency and lower self-efficacy
scores would find it most difficult to quit regardless of
the treatment method assigned.

It was not the assumption of

the principal investigator that all subjects would be able
to quit smoking.

In fact, this research may have had an

effect without any successful quitters.

For example, if

this study showed only a mean decrease in carbon monoxide
levels or number of cigarettes smoked, it would still be
considered valuable in a practical sense.
Hypotheses of the study
The hypotheses for the present study were derived from
assumptions of behavioral smoking treatment, literature on
the strategies associated with treatment success and
evidence implicating tobacco dependency and self-efficacy as
major determinants.

In accord with these sources, three

smoking cessation treatment methods were compared in two
groups of smokers.

This study was designed to investigate

the following null hypotheses:
Hypothesis 1:
There will be no significant difference (R<.05) in
pre/post mean exhaled carbon monoxide levels between
treatment groups when therapy (individual vs group vs
self-help) is manipulated in smokers with and without COPD.
Hypothesis 2:
There will be no significant difference (R< .05) in
pre/post mean number of daily cigarettes smoked between
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treatment groups when therapy (individual vs group vs
self-help) is manipulated in smokers with and without COPD.
Hypothesis 3:
There will be no difference in the frequency of success
between groups when therapy is manipulated.
Hypothesis 4:
There will be no relationship between demographic
variables and smoking cessation outcome between groups.
Hypothesis 5:
There will be no relationship between tobacco
dependency and smoking cessation outcome between groups.
Hypothesis 6:
There will be no relationship between self-efficacy and
smoking cessation outcome between groups.
Hypothesis 7:
There will be no relationship between smoking cessation
withdrawal symptoms and outcome between groups.
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CHAPI'ER TWO

REVIEW OF THE LITERATURE

Smoking and Chronic Obstructive Pulmonary Disease
Cigarette smoking is dangerous to health and has been
well established as a major cause of disease.

Despite this,

smoking continues to be a prevalent health-defeating
behavior, even among persons who have an illness related to
smoking (Mausner, 1970).

For many of these individuals,

continued smoking is a "self-inflicted suicide" and
inevitably contributes to the progressive deterioration of
their condition.
Chronic obstructive pulmonary disease (COPD) is a
frequent consequence of chronic cigarette smoke exposure.
The American Thoracic Society's definition of COPD is the
presence of a chronic, productive cough for at least three
months of the year for the last two years (U.S. Department
of Health and Human Services, Smoking and Health, 1987)

Two

disorders, emphysema and chronic bronchitis comprise the
majority of cases diagnosed as COPD. Chronic bronchitis and
emphysema are progressive, insidious in onset and may
ultimately result in death by respiratory and/or cardiac
failure.
Cigarette smoking has been implicated as the most
common cause of chronic bronchitis, emphysema and lung
cancer (U.S. Department of Health and Human Services,
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ability to quit.

Their study suggests that all COPD

patients will stop smoking would be accurate

in two out of

three cases.
Behavioral
in pulmonary

specialists

rehabilitation

rehabilitation

lung conditions.

medicine

programs.

Pulmonary

experts readily admit that they can provide

only supportive
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for infection,
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initiation
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regimen is best management

.

of

to their

that can be offered •

Often, the lungs are the only limiting system for the
activities of daily work and recreation (Fix, Daughton,
Kass, 1981).
Prigatano, Wright and Levin, (1984), showed restriction
in quality-of-life function and daily life activities in
patients with COPD.

In his study, the degree of physical

limitation was minimal, but the degree of psychosocial
limitation was more marked.

Fix et al. (1981) suggests that

certain psychological traits lead some people into
lifestyles that predispose them to smoke and subsequently
develop chronic lung disease.
Windsor et al. (1980) indicates that a significant
proportion of patients with COPD are receptive to smoking
behavior change and with education and support, will alter
their existing behavior of smoking.

Furthermore, he implies

that prevention by modification of smoking behavior clearly
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offers more hope than the possibility of any new treatment
for respiratory disease.

Unfortunately, little can be done

to directly modify pre-treatment variables such as rate and
years of smoking for those interested in quitting.

Perhaps,

participants for them whom a less favorable prognosis is
predicted can be monitored throughout treatment and be given
more intensive therapy.
The Utility of Pulmonary Function Testing
Current research suggests that the presence of a
chronic, productive cough, with additional abnormalities in
pulmonary function testing may identify a population whose
lung function deteriorates at a more rapid rate than normal
and who are at increased risk of death.

Fix et al. (1981)

suggested that smokers show reduced lung functions at all
ages compared to nonsmokers.
Petty, Pierson, Dick, Hudson and Walker (1976),
performed a follow-up of a prevalence study of respiratory
symptoms and chronic airway obstruction after a 6 to 7-year
interval.

Knowledge of the presence of chronic bronchitis

after the original study had no effect on subject's smoking
habits, although chronic bronchitis was significantly less
prevalent at follow-up among those who did stop smoking.
They also showed that smokers with a forced expiratory
volume in one second/forced vital capacity (FEVl/FVC) ratio
in 1967 < 60% showed approximately a three-fold larger
mortality rate than nonsmokers.

It was clear that the
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presence or absence of chronic obstructive

lung disease in
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feel compelled to come to work regardless of how sick they
feel.

Rather than face the reality of illness with its

feelings of guilt and lack of rewards, the individual may
avoid or deny the fact that he or she is ill (Mechanic,
197 8) •

The thrust of our culture is directed toward physical
perfection and health.

It's not surprising, then, that

people are taken off guard when the threat of illness
becomes a reality.

Suddenly there exists a tremendous

threat to the individual's self-system and subsequent
alteration of self.

Because of this threat, the individual

has to make adaptive changes depending upon the type of
illness, severity of the illness and threat to the person's
self-concept.

Adaptation to chronic disease is a lengthy

and ongoing process.

The illness may force the individual

to act differently than in complete health.
The social perspective of illness behavior takes into
account the norms involving sickness and response to
sickness.

The social perspective also determines the

conditions under which a person can claim illness and be
released from usual social obligations.

If we regard sick

people as having to be "looked after" rather than helped to
health, we may unwittingly reinforce their passive
tendencies and encourage them to leave it all to us.
The term "illness" can be used in two ways.

It can

refer to the medical disease model or to any condition that
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causes an individual to concern himself with his symptoms
and seek help.
latter.

the term "illness behavior" refers to the

The study of the patient's perspective is a useful

aspect of the analysis of health and disease.

Because

illness behavior affects the utilization of medical care,
the selection of patients who seek help from general
practitioners, clinics, or hospitals is usually biased.
(Mechanic, 1978).
Mausner (1970) found that the fact of being ill was a
major consideration in patients' decisions to stop smoking.
Cessation, however, was only limited to persons with severe
obstructive symptoms.

Probably the presence of symptoms,

the knowledge of abnormal radiographic findings, the
realization of the poor prognosis if their disease continued
its course, and the warnings from health care professionals
all contributed in varying proportions to the decision to
stop smoking.
For a COPD patient, knowing their illness is
irreversible may lead to feeling of hopelessness and fear of
losing control.

Independence and pride may be lost as

patients are forced to retire, change their recreational
activities and rely on others for assistance as their
disease progresses.

Feelings of inadequacy may result when

social roles change.

A major part of self image is related

to body image perceptions, attitudes and feelings that we
have toward our bodies (Dudley, Zitzman, Rugg, 1985).
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Health Belief Model and Smoking Cessation in The COPD
Patient
The Health Belief Model (Rosenstock, Strecher, Becker,
1988) contends that behavior change depends on the
interaction of three psychological factors:

how seriously

patients perceive a disease; how much benefit the patient
expects from the treatment; and how difficult, bothersome or
painful the patient expects therapy to be.

Because smoking

is often perceived as a pleasure, the immediate discomfort
of abstinence is pitted against the less immediate risk of
serious disease (Fix et al. 1981).

Although medical

opinions of the seriousness of disease have little
association with patient compliance rates, patients' views
of the severity and their perceived personal susceptibility
to a disease both affect compliance.

Higher compliance

rates are found among patients who perceive their medical
risks as great.

During asymptomatic periods, patients may

perceive their disease as less severe and predictably, when
patients are asymptomatic, medication compliance drops.
Consider this example:

A person may evaluate their

cigarette smoking because it is a threat to lung cancer.
They may deny their susceptibility, agree with the
seriousness of the disease but realize the perceived
treatment is poor and if they stop smoking, they loose the
benefits of being a smoker.
continue to smoke.

For these reasons, they may
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In reviewing the importance of social definitions in
response to illness, it is essential to remember the
character of the symptoms themselves.

Much of the behavior

of sick persons is direct product of the specific symptoms
they experience:

their intensity, the quality of discomfort

they cause and their persistence. (Mechanic, 1978).

Whether

a person recognizes a productive cough as a symptom of an
illness depends on how recognizable and the degree of
disturbance.

Because the natural history of the disease is

not widely disseminated by medical professionals, smokers
may not realize their susceptibility--that a productive
cough is the initial symptom of chronic lung disease.

They

may also not be aware of the seriousness of this seemingly
benign cough and its potential to lead to irreversible lung
damage.

Health care professionals need to place more

emphasis on explaining the clinical course of lung disease.
More effort should concentrate on having smokers appreciate
that their minor chronic symptoms are caused by smoking and
that nonsmokers experience fewer complaints.
Rosenstock's (1988) Health Belief Model states that if
smokers do not understand the course of the disease process,
they are likely to perceive that they will not be
susceptible.

Furthermore, they will fail to understand the

seriousness of their seemingly benign chronic cough and its
ultimate airflow obstruction.

Due to their physiologic

addiction to nicotine, they will view quitting smoking as a
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barrier with little benefit.

In a study by Hansen and

Malotte (1986), smokers were more likely than nonsmokers to
deny their susceptibility both for others and for themselves
as hypothetical lifelong smokers when asked to estimate the
probabilities of consequences from cigarette smoking.
In illness behavior, smokers who have COPD are already
in the medical care circle.

Perceived susceptibility is not

an issue because the patient already has the disease.
Perceived seriousness and barriers to quitting may take on
greater significance (Rosenstock et al. 1988).

If we look

at the issue of smoking cessation from the viewpoint of the
person who has COPD, one may see healthy smokers who need to
quit but then continue to be healthy.

On the other hand,

one sees sick smokers who also need to quit but continue to
stay sick.

The instrumental value of quitting may not

provide enough incentive or motivation to quit smoking.
Tobacco Dependency
Cigarette smoking continues to be an extremely
tenacious addiction.

Evidence now clearly indicates that

nicotine, similar to alcohol and opiates, is a potent
dependence-producing drug (Henningfield & Jasinski, 1983;
Jaffe & Kanzler, 1979).

Most smokers say they want to quit

but only one in three stops permanently before age 66
(Russell & Jarvis, 1985).
Conclusions of the 1988 Surgeon's General Report are 1)
cigarettes and other forms of tobacco are addicting;
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2) nicotine is the drug in tobacco that causes addiction,

and 3)

the pharmacologic and behavioral processes that

determine tobacco addiction are similar to those that
determine addiction to drugs such as heroin or cocaine (U.S.
Department of Health and Human Services, 1988).
The level of tobacco dependence will vary across
smokers.

Previous studies have shown that the higher the

tobacco dependency, the more recalcitrant the smoker is to
smoking cessation attempts (U.S. Department of Health and
Human Services, Smoking and Health, 1987).
Glasgow, Klesges, Klesges, Somes, (1988) and Klesges et
al. (1988) found in two separate studies that subjects with
heavier, more recalcitrant smoking habits are the most
likely to join a stop-smoking program but the least likely
quit.
Recidivism is a major obstacle to successful cessation
efforts.

studies show that quitting is often a result of

persistence.

In one study, only 25% of the participants

quit on the first try, but by the fourth attempt, 73.4% of
the total participants had kicked the habit (U.S. Department
of Health Education and Welfare, 1979).

Patients with COPD

have higher rates of quitting the smoking habit than do
smokers generally, but many continue to smoke to the end.
Sachs et al. (1987) reported that a typical patient referred
to a lung specialist has tried 8.2 times to seriously stop
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smoking in the past using a mean of 2.3 totally different
techniques.
The ability to stop smoking appears to be related to
the habit itself.
before age 20.

Over 90% of all smokers begin smoking

An early age of initiation is inversely

related to current smoking status, that is, the earlier one
begins smoking as a teenager, the less likely that
individual will be successful in giving up smoking as an
adult.

An earlier age of smoking initiation is strongly

correlated with becoming a heavy smoker, thus further
increasing the risk of premature death and disability (U.S.
Department of Health and Human Services, Smoking and Health,
1987) •
Daughton et al. (1980) showed that only pack-years
emerged as a significant discriminant between patients at
follow-up who had quit and those who continued to smoke
(Q<.05).

The only relapses occurred in heavy smokers with

greater than a 55 pack-year history.

Nelson (1977) showed

similar findings that in a healthy population, pack-years is
one of the best predictors of smoking cessation, with the
heaviest smokers being least likely to quit.

A

well-established pattern of smoking appears difficult to
change regardless of whether a heavy smoker is healthy or
has COPD.
Heavy smokers, compared to lighter smokers are at
increased risk of death by heart disease, lung cancer and
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Kasl (1974) showed that among the sociodemographic
variables, males and older married persons have better
success.

Wife's disapproval of smoking increased the chance

of success, but not the other way around; in fact,
disapproval from friends and relatives increased the female
smokers' chances of failure (Coppotelli & Orleans, 1985).
The mechanisms underlying gender differences in smoking
cessation maintenances have not been systematically
explored, but women react more adversely to unwanted changes
accompanying quitting, especially temporary moodiness and
weight gain, because they find such changes to be greater
social liabilities (U.S. Department of Health and Human
Services, Healthy People, 1979).
Dudley et al. (1977) confirmed that patients with high
psychosocial assets have several behaviors to substitute for
that of smoking.

These patients, he suggested, are

psychologically stable and their psychologic comfort is not
seriously threatened if they need to stop smoking.

Daughton

et al. (1980) also reported that psychosocial assets and
pack-years smoking history significantly differentiated
smokers from ex-smokers at follow-up.
Kasl (1974) concludes that persons who expect to be
successful, are confident of their ability to quit, are
accepting of treatment, and attend regularly, are more
likely to quit smoking.

Those who drop out of treatment at

a point where they have already quit are more likely to be
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successful at follow-up than those who stay in treatment;
but dropouts who don't quit are almost certain to remain
failures.
Self-efficacy
Because smoking continues to be characterized by high
rates of recidivism, investigators have turned to cognitive
theories such as Bandura's (1977) concept of self-efficacy.
Self-efficacy is an element of Bandura's (1986) Social
Cognitive Theory.

Bandura holds that behavior is

determined, in part, by cognitive factors which mediate
eventual behavior change through expectancies and
incentives.

Self-efficacy is the expectancy about ones own

competence to perform the behavior needed to influence
outcomes.
Bandura (1977) outlines the role of self-efficacy in
the paradigm of a person engaging in a behavior that will
have a subsequent outcome:
PERSON

-------------->

BEHAVIOR

------------>

OUTCOME

r
Efficacy

r
Outcome

Expectations

Expectations

In order for a man or a woman (PERSON) to quit smoking
(BEHAVIOR) for health reasons (OUTCOME), he or she must
believe both that cessation will benefit their health
(OUTCOME EXPECTATION) and also that she is capable of
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quitting (EFFICACY EXPECTATION) (Strecher, Devellis, Becker,
Rosenstock, 1986).
It should be emphasized that efficacy expectations
reflect a person's beliefs about capabilities and
behavior-outcome links.

Bandura (1982) maintains that

efficacy expectations reflect a person's perceived, rather
than actual, capabilities, and that it is these perceptions
and not one's true abilities that often influence behavior.
Bandura (1986) states that self-efficacy information is
derived from four sources:

enactive, or performance

attainments; vicarious experience; verbal persuasion and
physiological states.
When the behavior change is believed to lead to desired
consequences, but the change is difficult to make,
self-efficacy considerations are probably paramount.
Bandura (1982) states that self-efficacy influences all
aspects of behavior, including the acquisition of new
behaviors or the inhibition of existing behaviors.

The

self-efficacy construct has been examined in the area of
smoking and smoking cessation studies through a variety of
survey and experimental studies.

survey studies of

self-efficacy reviewed suggest strong associations between
self-efficacy and behavior change progress, maintenance and
relapse indicators.

This research has been extremely

helpful in delineating the role of efficacy expectations
from outcome expectations as well as other psychological
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constructs, such as stress and locus of control.

Ratings of

self-efficacy were found to discriminate active quitters
from continued smokers, joiners of smoking cessation
programs from non-joiners and successful from unsuccessful
short- and long-term quitters.

Experimental manipulations

of self-efficacy suggest that self-efficacy may be enhanced
and this enhancement is related to subsequent smoking
cessation and reduction (Strecher et al. 1986).
Investigations in smoking cessation strongly support
the idea that the expectation of success and perceived
self-efficacy are among the most important factors affecting
smoker behavior change (Condiotte & Lichtenstein, 1981;
DiClemente, 1981; Yates & Thain, 1985).

Condiotte and

Lichtenstein (1981) also demonstrated that ex-smokers
self-efficacy ratings were situation-specific, i.e., their
relapses occurred in situations where self-efficacy was
lowest.

In contrast, individuals who were able to maintain

post-treatment abstinence were found to have higher
self-efficacy scores than recidivists (DiClemente, 1981).
Barrios and Niehaus (1985) showed that successful
quitters reported higher self-efficacy than unsuccessful
quitters.

In addition, low self-efficacy has been shown to

predict which smokers may relapse.

Strecher et al. (1986)

has shown in studies where other psychosocial constructs are
examined, self-efficacy consistently emerges as a powerful
predictor of behavior.

It is important to understand that

36

the concept of self-efficacy relates to beliefs about
capabilities of performing specific behaviors in particular
situations, self-efficacy does not refer to a personality
characteristic or a global trait that operates
independently.

This means that an individual's

self-efficacy expectations will vary greatly depending on
the particular task which confronts the individual (Strecher
et al. 1986).
Chronic illnesses which involve modifying lifelong
behaviors require a good deal of confidence that one can, in
fact, alter their lifestyles before such an intervention is
possible.

A growing body of literature supports the

importance of self-efficacy in helping to account for
initiation and maintenance of behavior change.

In the realm

of chronic diseases, much more emphasis is likely to be
needed on skill training to enhance self-efficacy.

Where

complex behavior patterns are required to maintain or
restore health, enhancement of self-efficacy will usually be
required.

This would certainly be the case in the

modification of complex lifestyle practices such as
cigarette smoking.
Individual. Group and Self-Help Treatment Methods
The interpersonal environment significantly influences
cessation of smoking.

Little research, however has been

devoted to mobilizing social support as an intervention
modality.

Most of the smoking cessation research on the
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to have the potential to improve main~enance of treatment
effects at different points in the cessation process
(Glasgow, Schafer, O'Neill 1981).

Self-help intervention

may appeal to smokers who would not participate in more
intensive treatment (Pechacek, 1979).
Poor follow-through under self-administered conditions
is unfortunately a frequent characteristic of self-help
behavior therapy programs.

Pechacek (1979) has suggested

that traditional group or individual treatments can possibly
be used to supplement self-help interventions for the more
recalcitrant smokers.

Klesges et al. (1988) suggests the

use of a stepped care approach.

That is, perhaps lighter

smokers might be treated differently (e.g. with self-help)
than heavier smokers (who may be targeted for more intensive
interventions group or individual sessions--once they have
failed at a particular level).
Therapist Contact
It appears that the more complex the behavior change
strategy, the more important the therapist.

Glasgow et al.

(1981) showed that therapist contact improved treatment
effectiveness for the more detailed learning treatment
program but that subjects in the more straightforward
condition did as well on their own as they did with
therapist assistance.

Pechacek (1979) reported that the

importance of a warm "client-therapist relationship" in
successful smoking cessation. Glasgow et al.

(1981)
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topic has examined the effects of varying frequency and
nature of therapist support.
inconclusive.

Results are contradictory and

Some studies have evaluated the effects of

group sessions vs individual counseling with neither
approach demonstrating a clear-cut superiority (Windsor &
Bartlett, 1984).
Some people find the social support of a group
especially appealing.

Sirota et al.

(1985) found that group

members rated the influence and support of fellow
participants and group leaders as two of the most helpful
components of his study.
One major conclusion of the 1979 Surgeon General's
Report on Smoking and Health was that little is known about
the millions of smokers who have quit on their own (U.S.
Department of Health, Education and Welfare, 1979).

It has

been estimated that 95% of the over 30 million smokers who
have quit since 1964 have done so on their own.

If we know

very little about how smokers quit on their own, less is
known about ways to facilitate this self-help phenomenon.
A large number of self-help smoking cessation manuals have
been available commercially for years.

Such approaches are

believed to be worthy of scientific investigation because of
easy availability, low cost, and possible client
self-attribution of success rather than the therapist
(Windsor et al. 1984).

The role for self-help or minimal

intervention is irrefutable.

Self-help interventions appear
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discovered that degree of therapist contact was associated
both with program adherence and with self-reported treatment
success.
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CHAPI'ER THREE

METHODS
Design
The experimental design used in this study was repeated
measures factorial design using a control group for
comparison.

Tobacco dependency and self-efficacy were to be

used as covariates if homogeneity of regression occurred.
This study was an experimental study because the independent
variable of treatment was manipulated through random
assignment.

The study also had causal-comparative aspects

because attributes such as being a normal smoker or having
COPD, having high or low self-efficacy or high or low
tobacco dependency have already occurred and cannot be
manipulated.

Correlational statistics were also applied to

determine whether a relationship between the variables and
smoking cessation outcome could be assessed.

In effect,

this study examined the effectiveness of three smoking
cessation treatment methods in smokers who have COPD and
normal smokers while trying to control for confounding
variables verified by the literature review.

This study was

designed to answer the basic research question:

What

smoking cessation therapy works best for different types of
smokers?
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Table

3.1

Graphic

representation

CD
CD
CD
Definition of Variables

of study design.

R

xl

R

x2

R

X3

CD
CD

CD

The dependent variables in this study were exhaled
carbon monoxide levels and self-reported number of
cigarettes smoked.

Operationally defined, a non-smoker was

any subject with a carbon monoxide level of less than 8 and
abstinence of smoking for 7 days obtained from diary cards
at the posttest.
Smoking cessation therapy was manipulated as the
independent variable.

After determining smokers with COPD

and those without subjects were randomly assigned to one of
three treatment groups:

1) individual therapy, 2) group

therapy, and 3) self-help therapy.
Table 3.2
Number of subjects in each cell.

Normal

COPP

Individual Therapy

10

10

Group Therapy

10

10

Self-help materials

10

10
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Other variables included demographic information such
as age, sex, duration of smoking, pack-years, tobacco
dependency scores, self-efficacy scores and smoking
withdrawal symptoms of nicotine craving, irritability,
frustration, anger, anxiety, difficulty concentrating, and
restlessness.
Main Effects
There were three main effects in this study:
2} group and, 3} treatment method.

l} time,

The main effects were

organized into a 2x2x3 univariate factorial design.

There

were two levels of time, (pre-post}, two levels of group
effect (normal smokers and COPD} and three levels of
treatment effect, (individual therapy, group therapy,
self-help therapy}.

Again, the basic purpose of the study

was to compare three levels of smoking cessation therapy in
two groups of smokers before and after treatment.

The

treatment method effect is classified as a manipulative
variable or instructor variable.

In contrast, the group

effect is an organismic or attribute variable.
Smoking Cessation Therapist
The smoking cessation therapist was a female Physician
Assistant (graduate student and principal investigator} with
over four years experience in pulmonary medicine and smoking
cessation.

Therapist training consisted of reading relevant

background material.

Therapy was standardized across groups
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by following the American Cancer Society's FreshStart
Facilitator's Manual.
FreshStart Program
FreshStart is a smoking cessation program sponsored by
the American cancer Society and offered in various locations
throughout the nation.

The American Cancer Society's

FreshStart Participant's Manual is a 16-page book with an
accompanying 17-page Facilitator's Guide.

The FreshStart

Guide consists of four sessions intended to be given in four
one-hour group sessions to take place twice weekly over a
two-week period.

The American Cancer Society follows the

intended format.

The FreshStart Facilitator's Guide

suggests that although the above format is suggested, the
program can be very flexible as long as the core curriculum
is always presented.

The FreshStart Facilitator's Guide

contains a summary agenda and objectives for each session
followed by details of the session's content.

Each session

includes four phases: (1) Individual Attention, (2)
Strategies and Information, (3) Review and Discussion and
(4) Assignments.
Session I describes three aspects of smoking:

1)

chemical addiction, 2) habit and 3) psychological
dependence.

It discusses approaches to stopping and

physiological effects of smoking.

The withdrawal symptom

section of Session II was discussed at Session I in this
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since participants

Session

I their target

Session
including

were asked to make the day after

quit smoking day.

II focuses on progressive
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training
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thinking.
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obstacles

relaxation
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off cigarettes.

of weight management,

and master

all

It follows with a

alcohol

and interpersonal

support.
Session
improvements

the long-term

benefits

community
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(3)

having

(2)

from a midwestern

from approximately

criteria
expressing

edition

included

200 respondents
of the local

(1)

being at least

a sincere desire

were self-selected
advertisement.

advertisement

an answering
general

smoke-free.

no other smoking household

cessation

newspaper

of staying

using no other forms of tobacco

Participants
smoking

main pitfalls

smokers

in the Sunday

Selection

19 years of age,

(4)

describe

of Subjects

Sixty adult cigarette

smoking,

to name any physical

they have experienced,

and discuss
Selection

IV asks participants

machine.

description

over the telephone.

to quit

or nicotine

and

members.
by their

interest

All 200 respondents

in a
to the

left their name and phone number on
Respondents

of the program

were called

and given a

and selection

Each subject was asked

criteria

if they had a
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diagnosis

of COPD/chronic

cough productive

bronchitis

of mucous

or if they have had a

on most days of the week for at

least three months

of the year for the last two years

(American Thoracic

Society's

bronchitis--U.S.
Smoking

Department

and Health,

study was designed
smoking

productive

and Human Services,

Respondents

treatment

and 3)

were told that this

methods

self-help

1)

therapy·in

no financial

five visits

of three

individual

cough and those who do not.

study will involve

therapy

smokers

who have a

They were told the

over four weeks

and carried

who were eligible

were divided

and willing

into two groups:

to

smokers without

productive

cough

(normal smokers group) and smokers

productive

cough

(COPD group).

smokers was stratified
randomly

assigned

subjects

were randomly

random

2)

obligations.

Respondents
participate

of Health

of chronic

to look at the effectiveness

cessation

group therapy

1987).

definition

sampling

Therefore,

based on symptoms

to treatment

and scheduled

with a

the sample of

and subjects

groups by stratum.

selected

a

were

Thirty

from each group by simple

for their first visit.

Procedure
At the first visit,
and sign two IRB-approved
themselves.

Subjects

confidential.
Assessment

subjects
consent

the Fagerstrom

to read

forms and keep one for

were told that all records

They also completed

Profile,

were instructed

will remain

the Demographic
tobacco

Pulmonary

dependency
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questionnaire and the Confidence self-efficacy
questionnaire.

In addition, subjects were asked to report a

daily baseline number of cigarettes smoked and the duration
of their productive cough.

All subjects were asked to

provide a sample of exhaled air to confirm that they were a
smoker.

Group assignments were made by having the subject

randomly pick a slip of paper (one slip each for Individual,
Group and Self-help) out of a bag which named which therapy
the subject would get.

Subjects were reminded that the

therapist had no control over which therapy was chosen.
Subjects were told if they were unsuccessful at their quit
smoking attempt, they may try one of the other groups after
four weeks.

Regardless of which group was chosen, everyone

received the American Cancer Society's Participants' manual
and also Session I at the first visit.
meetings were with one to two s~bjects.

Initial intake
Subjects were also

instructed how to self-monitor their smoking and withdrawal
symptoms using diary cards.

Subjects were asked to target

the next day as their quit smoking day and attempt to quit
entirely.

All subjects were given a beeper number to reach

the therapist at anytime day or night for the entire four
weeks.

Subjects were encouraged to call the therapist if

they had a severe craving for a cigarette or for any reason.
Individual Therapy
Twenty subjects (10 normal smokers and 10 smokers with
COPD) who chose individual therapy met with the therapist
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individually

at weekly

four week period.

intervals

for thirty minutes

At each visit,

the diary for the previous

week was reviewed

and new information

in the FreshStart

Manual was discussed.

air was obtained
card was given

over the

from the next session
A sample of exhaled

for a carbon monoxide

level and a new diary

for the next week.

Group Therapy
Twenty

subjects

(10 normal smokers

and 10 with COPD)

who chose group therapy met with the therapist
four to six subjects

at weekly

the four week period.
each visit,

from the next session

was discussed.

treatment,

week was reviewed

at
and

in the FreshStart

A sample of exhaled

for a carbon monoxide

of

for one hour for

As with the individual

the diary for the previous

new information
manual

intervals

in groups

air was obtained

level and a new diary card was given

for the next week.
Self-help
Twenty

Therapy

subjects

who chose self-help
Society's

therapy

FreshStart

asked each self-help
sessions
visit
week.

manual

smokers and 10 with COPD)

received

the American

and Session

subject

on their own.

I.

to work through

They were scheduled

Other than being able to contact

the remaining
for their next

program.

call the third

the therapist

did not have any organized

the four-week

Cancer

The therapist

in four weeks and were given a reminder

time, the subjects
during

(10 normal

at any

sessions

At the final visit,

subjects
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returned their diary cards for the last four weeks, reported
their experiences and were asked to provide a sample of
exhaled air to assess carbon monoxide levels.

Subjects who

did not return for their final visit were called and asked
if they had quit smoking, how many cigarettes they were
smoking a day, and asked to return for an exhaled carbon
monoxide level.
Measures
Self-monitored Diary Card
Orleans and Shipley (1982) and Petitti, Friedman, and
Kahn (1981) suggest that self-report has been recommended as
the single most valid measure of smoking.

The development

of self-monitoring habits in a smoking program may
facilitate the practice of other helpful behaviors learned
during treatment.

Self-monitoring may present the clearest

form of continuous disruption of the smoking routine
(Kamarck & Lichtenstein, 1988).

This disruption may bolster

awareness of smoking cues and confidence in ones' ability to
control the smoking habit.

Pomerleau et al.(1978) found

that smoking abstinence at the end of an eight-session
multicomponent treatment program was associated with a
larger number of completed self-monitoring forms during the
program.
Subjects monitored number of cigarettes smoked and
withdrawal symptoms on a daily basis throughout the
four-week treatment program.

Withdrawal symptoms were rated
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on a scale of O=none
4=severe.
nicotine,
difficulty

(absent),

Withdrawal

l=slight,

symptoms

irritability,
concentrating

2=mild,

3=moderate,

included craving for

frustration,

anger,

and restlessness.

symptoms and number of cigarettes

anxiety,
Withdrawal

smoked were summed and

averaged across 1-week intervals to provide two measures:
average number of cigarettes
intensity of withdrawal

1)

smoked per day and 2) mean

symptoms.

See Appendix

D for diary

card.
Carbon Monoxide

Levels

An objective physiological

index of recent cigarette

smoking was obtained by determining
carbon monoxide

(CO)

the concentration

in expired breath samples.

of

Daughton et

al. (1980), suggests that carbon monoxide is one of the most
easily understood dangers for smokers and co intake may
represent a more immediate risk, one that can be confirmed
by feedback with a monitoring device.
Approximately 10 to 20 ml of carbon monoxide is inhaled
with each cigarette smoked.

The co diffuses across alveolar

membranes and once absorbed, is bound to hemoglobin.
Carboxyhemoglobin in the blood is in equilibrium with
alveolar air after breath-holding.
CO

Therefore, the amount of

in expired air provides a rapid and accurate non-invasive

measure of carboxyhemoglobin.
The major limitation of using co as a measure of
smoking behavior is that the time of day and the length of
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within one minute.

A typical non-smoker would produce a

carbon monoxide recording of less than 8 ppm (corrected for
ambient carbon monoxide).

Smokers range slightly greater

than 10 ppm in a non-inhaler to well over 75 ppm in heavy
smokers.

A carbon monoxide reading of 8 or greater

(corrected for ambient CO) will categorize the subject as a
smoker.

This objective measurement corroborated patient

reports of smoking cessation.
Demographic Pulmonary Assessment Questionnaire
The demographic questionnaire asks age, sex, duration
of smoking, questions regarding a productive cough

and

categorical information on the number of packs smoked per
day.In addition, the investigator asked the subjects for the
actual number of cigarettes smoked and the duration of their
chronic, productive cough if they reported having one.

The

latter information was important in dividing subjects into
groups based on the American Thoracic Society's definition
of chronic bronchitis.

Subjects must have had a chronic,

productive cough for at least two years to be in the COPD
group.

This information was not included on the

questionnaire.

Pack-year history was obtained by using the

categorical information on the questionnaire and multiplying
by the total number of years smoked.

See Appendix E for the

Demographic Pulmonary Assessment Questionnaire.
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Fagerstrom Tobacco Dependency Questionnaire
Fagerstrom (1978) developed an 8-item questionnaire
aimed at estimating physical dependence on nicotine.

The

items cover various aspects of smoking behavior (number of
cigarettes smoked per day, brand smoked, time of day smoking
occurs, ability to control smoking in no-smoking areas and
so on).

Consistent and significant correlations from these

indicators to the questionnaire (intended to measure
physical dependence) have been established (Fagerstrom,
1984).

The higher the score on the dependence

questionnaire, the higher the dependency.

The range of

scores of the questionnaire is from 0-11 with 0-6 considered
low dependency scores and 7-11 as high-dependency scores
(Fagerstrom, 1984).
The Fagerstrom nicotine dependence scale enables
patients to acknowledge their degree of dependence and to
increase their general awareness of the dependency
(addiction) concept and perhaps justify dependency as a
cause of past quitting failures.

See Appendix F and G for

the Fagerstrom Tobacco Dependency Questionnaire and
instructions for scoring.
Confidence Self-efficacy Questionnaire
Barrios and Niehaus (1985) showed that successful
quitters reported higher self-efficacy ratings than
unsuccessful quitters.

This provides some validation for
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the Confidence questionnaire as a screening device and as a
rough predictor of likelihood of success in treatments.
The Confidence Questionnaire is designed to assess the
magnitude, strength and generality of self-efficacy
expectations in smoking situations.

A modified version of

the questionnaire used by Condiotte and Lichtenstein (1981)
will be employed in this study.

Yates and Thain (1985) used

the modified version to look at self-efficacy as a predictor
of relapse following smoking cessation.

The two items with

the largest loadings on each of the seven clusters
identified in a cluster analysis by Condiotte and
Lichtenstein (1981) were used to construct the 15-item
questionnaire (Yates, 1985).

The items contain situations

incorporating both intrapersonal and interpersonal mood
states.
Subjects will be instructed to designate on a 100-point
probability scale (expressed in percentage units), ranging
in 10 interval units, the probability that they would resist
the urge to smoke in that situation.

To provide an index of

self-efficacy strength, the magnitude of expectancy scores
across situations will be added and divided by the total
number of items.

Alpha reliabilities range from .69

(interpersonal negative mood states) to .94 (intrapersonal
negative mood states) (Baer and Holt, 1986).

Examination of

the psychometric properties of the Confidence questionnaire
suggest it is highly reliable and primarily unidimensional.
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See Appendix H for the Confidence Self-efficacy
Questionnaire.
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CHAPI'ER FOUR

RESULTS
This study compared the effectiveness of three smoking
cessation treatment methods in two groups of smokers--normal
smokers and smokers with COPD in an attempt to find the best
"person-intervention-fit."

As previously stated, the

hypotheses for this study were derived from an extensive
literature review.

This review revealed evidence

implicating tobacco dependency and self-efficacy as major
determinants and supported the need for individualizing
smoking cessation therapy.
Cigarette smokers who answered a newspaper
advertisement for a smoking cessation study were divided
into two groups based on the presence or absence of a
productive cough.

Thirty smokers from each group were

chosen by simple random sampling for a total of 60 subjects.
Subjects were further randomized into one of three
treatments:

1) Individual 2) Group or 3) Self-Help therapy.

Ten subjects each from the normal smokers group and COPD
group comprised the number in each treatment.
Population Description CN=60)
Twenty (33.3%) males and forty (66.7%) females
participated in the study.

As one group, the subjects

averaged 39.667 (SD=ll.515) years of age, reported a mean
smoking rate of 24.3 (SD=9.487) cigarettes per day at
baseline, had smoked an average of 21.917 {SD=ll.053) years
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and had a mean pack year history
60 subjects
of 6.667

of 29.367

had a mean Fagerstrom

(SD=l.838)

tobacco

(SD=19.300).
dependency

and a mean self-efficacy

The

score

score of 51.217

(SD=l6.617).
Description

by Group

Descriptive
COPD

Cn=30)

data for the two groups:

(n=30 in each group)

normal

is shown in Table

smokers and

4.1.

Table 4.1
Means and Standard
Smoking,

Deviations

Pack-years,

Tobacco

by Group for Age. Duration
Dependency

and Self-efficacy

Normal

COPD

SD

M

SD

M

Age

35.667

10.479

43.667

11.263

Years Smoked

17.500

9.909

26.333

10.489

Pack-Year

20.967

11.775

37.767

21. 754

6.400

1. 714

6.933

1.946

55.467

14.438

'46,967

17. 775

Tobacco Dependency
Self-Efficacy

of

The thirty subjects in the normal smokers group, 9
males (30%) and 21 females (70%) averaged 35.667 (SD=l0.479)
years of age, reported a mean smoking rate of 24.833
(SD=8.494) cigarettes per day at baseline, had smoked for an
average of 17.500 (SD=9.909) years and had a mean pack-year
history of 20.967 (SD=ll.775).

The mean Fagerstrom score

was 6.400 (SD=l.714) and mean self-efficacy score was 55.467
(SD=14.438). The thirty subjects in the COPD group
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11 males

(36.7%) and 19 females

(SD=ll.263)
28.333

(63.3%) averaged

years of age, reported

(SD=l0.565)

cigarettes

a mean smoking

of 26.333

(SD=l0.489)

pack-year

of 37.767

(SD=l0.489).

Fagerstrom

score was 6.933

score was 46.967

years and had a mean
The mean

(SD=17.775).

COPD group are higher with the exception

indicate

had

(SD=l.964) and mean self-efficacy

As shown in Table 4.1, the majority

self-efficacy

rate of

per day at baseline,

smoked an average
history

43.667

scores.

of the means
of the

The lower self-efficacy

means

that the COPD group had lower self-efficacy

their normal
Description

in the

than

smoker counterparts.
by Treatment

Descriptive

Cn=20)

data for the three treatments:

group and self-help
shown in Table 4.2.

therapy

(n=20 in each treatment)

Descriptively,

note that the three treatment

individual,

groups

it is interesting

is
to

look very similar.
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Table 4.2
Means and Standard Deviations by Treatment for Age, Duration
of Smoking, Pack-Years, Tobacco Dependency and Self-efficacy
Therapy
Group

Individual
SD

M

M

Self-Help
M

SD

SD

Age

40.100

12.953

41.050

11.883

37.850

9.853

Years Smoked

23.050

12.521

22.050

11. 395

20.650

9.472

Pack-Years

31.400

20.582

27.650

19.754

29.050

18.312

Tobacco Depen

6.050

1.820

6.350

1. 927

7.600

1.429

Self-Efficacy

~4,900

19,200

53,850

12 ,001

44,900

16, ZZl

Analyses of Research Hypotheses
The hypotheses were analyzed by conducting tests for
homogeneity of regression, discriminant analyses and.
Chi-Square using the SPSSX program package.

Further

analyses using a 3-way, univariate, analysis of variance
with repeated measures and its simple effects were conducted
by using the BMDP program package.
Classification of a Non-smoker
Subjects were counted as non-smokers if they did not
smoke during the last seven days of the study.

The carbon

monoxide cutting score for classifying smokers was set at 8
parts per million (ppm), which is somewhat restrictive given
Lando's (1975) finding that non-smokers can produce reading
between 5 and 11 ppm.

The carbon monoxide measure was used

as the final standard if indicators seemed discrepant among
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reported non-smokers.

Evidence of a smoking episode during

the last seven days resulted in the subject's classification
as a smoker.
Hypotheses 1:
There will be no significant difference (R<.05) in
pre/post mean exhaled carbon monoxide levels between
treatment groups when therapy (individual vs group vs
self-help) is manipulated in smokers with and without COPD.
A test for homogeneity of regression using Fagerstrom
tobacco dependency scores and Confidence self-efficacy
scores was performed.

Using a Wilk's lambda test, a

significance level of .067 was reached which did not exceed
the standard score of .10 for homogeneity of regression.
Therefore, violation of homogeneity of regression occurred
which was prohibitive for using these values as covariates.
A split-plot analysis of variance for repeated measures
using carbon monoxide levels was performed.
the factorial analysis is shown in Table 4.3.

The summary of
As seen in

this table, time was the only main effect that was found to
be significant at R=.01.

Thus, there was a statistically

significant reduction in carbon monoxide levels
pre-treatment to post-treatment.

A two-way Timex Treatment

effect was significant at R=.05.

The remaining two-way

interactions (Timex Group and Group x Treatment) were not
significant.

There was no three-way interaction effect.

When comparing pre and post carbon monoxide levels, grouping
effects were not found to be significant.
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Table 4.3
Spllt·Plot Analysis of Variance for Repeated Measures Using Pre and Post Carbon Monoxide levels.
p

Effect

OF

SS

HS

F

GrOLp

1,54

44.40833

44.40833

0.46

0.4993

T reat111ent

2,54

85.016667

42.508333

0.44

0.6445

Time

1,54

2332.008333

2332.008333

31.34

0.0000*

Timex Treatment

2,54

503.116667

251.558333

3.38

0.0414**

GrOLp x Treatment

2,54

217.816667

108.908333

1.13

0.3291

Timex Group

1,54

165 .675000

165.675000

2.23

0.1415

Timex Group x Treatment 2,54

43.850000

21.925000

0.29

0.7460

*Indicates statistical significance at R=.01 level.
**Indicates statistical significance at R=.05 level.
Post-hoc analyses were conducted to investigate the
Timex Treatment interaction effect.

Table 4.4 shows the

means and standard deviations of pre-test and post-test
carbon monoxide levels by treatment.
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Table

4.4

Means.

Standard

Pre-test

Deviations

and Post-test

and Significance

Carbon Monoxide

CCO)

Levels

of

Levels by

Treatment.
Therapy
Individual***
M

Pre

co

23.950

SD
12.176

Group****
M

26.200

co
14.200
9.006 121200
*With 2,54 degrees of freedom,
and 12=0.5280.
**With 2,54 degrees of freedom,
and 12=0.0540.
***With 1,54 degrees of freedom,
12.78 and 12=0.0007.
****With 1,54 degrees of freedom,
23.77 and 12=0.0000.
*****With 1,54 degrees of freedom,
and 12=0.2100.

Post

Self-Help*****

SD

SD

M

10.385

22.750

4.115*

8.065
19.350 9.483**
the F statistic was 0.65
the F statistic was 3.08
the F statistic was
the F statistic was
the F statistic was 1. 55

An investigation of the simple effects was performed
when holding time constant and looking across treatment.
The probability level for mean pre-test carbon monoxide
scores was 0.5280 and for mean post-test carbon monoxide
scores was .0540.

While this test did not reach statistical

significance at 12=.05, it appears that there was a major
difference between carbon monoxide values across all
treatments pre-test to post-test.

Further analysis

investigated the simple effects when holding treatment
constant and looking across time.

Individual and Group

therapy showed significantly different pre to post carbon
monoxide levels than Self-help therapy.

The change in

co
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levels pre-to post-treatment for Group and Individual
therapy was more substantial whereas there was no apparent
change in Self-help therapy.

In this study, these two

treatments (Individual and Group) appeared to be more
effective than Self-help therapy.

However, further

differentiation between these two significant treatments is
not possible.

As seen in Table 4.4, the largest reduction

in CO levels took place in the Group therapy, followed by
Individual and then Self-help therapy.
Hypothesis 2:
There will be no significant difference (p<.05) in
pre/post mean number of daily cigarettes smoked between
treatment groups when therapy (individual vs group vs
self-help) is manipulated in smokers with and without
COPD.
A split-plot analysis of variance for repeated measures
using number of cigarettes smoked was performed.
shows a summary of the factorial analysis.
significant main effect at p=.01.
also significant at p=.05.
significant.

Table 4.5

Time was a

Group main effect was

Treatment effect was not

There were no interaction effects.
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Table 4.5
Split-Plot Analysis of Variance for Repeated Measures Using
Pre and Post Number of Cigarettes Smoked.
MS

F

p

725.208333

725.208333

6.15

0.0163**

2,54

529.06667

264.533333

2.24

0.1161

1,54

6735.008333

2,54

148.066667

74.033333

1.11

0 3372

Group x Treatment

2,54

523.466667

261.733333

2.22

0.1187

Timex

Group

1,54

60.20833

60.208333

0.90

0.3464

Timex

Group x Treatment 2.54

0.233333

0.00

0 9965

Effect

DF

Group

1,54

Treatment
Time
Timex

Treatment

SS

6735.008333 100.92

0.466667

0.0000*
I

!

*Indicates statistical significance at R=.01.
**Indicates statistical significance at R=.05.
Table 4.6 shows the means and standard deviations of
the number of cigarettes smoked at baseline and after
treatment.

All 60 participants in this study were clearly

able to reduce the number of
cigarettes smoked.
Table 4.6
Means and Standard Deviations of Pre/Post Number of
Cigarettes Smoked.
Time

Pre <N-60)
M

Number of Cigarettes Smoked

26.583

Post (N-60)

SD

M

9.666

11. 600

SD
10.456
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Table 4.7 shows the means and standard deviations for
pre/post number of cigarettes smoked by Group.

Normal

smokers were able to reduce their cigarette number by
slightly more than smokers with COPD.

Also seen in Table

4.7, smokers with COPD smoked more than normal smokers.
Table 4.7
Means and Standard Deviations for Pre/Post Number of
Cigarettes Smoked by Group.
Group
Normal Smokers (n-30)

COPD (n-30)

M

M

SD

SD

Pre number of cigarettes smoked

24.833

8.494

28.333

10.565

Post number of cigarettes smoked

8.433

8.585

14.767

11.313

Hypothesis 3:
There will be no difference in the frequency of success
between groups when therapy is manipulated.
Using a Chi-Square statistic for normal smokers and
COPP, it was found that in neither group was there a
significant relationship between treatment and smoking
cessation outcome over chance.

Table 4.8 and 4.9 show the

frequencies and percentage quit rates by Treatment for the
two groups.

In the normal smokers group, 26.7% of the

subjects successfully quit smoking, whereas, 20% of the COPD
group were able to quit.
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Table 4.8
Frequency Distribution of Smoking Cessation Outcome by
Treatment for the Normal Smokers Group.
Non-smokers

Smokers

Individual (n=lO)

2

8

Group (n=lO)

4

6

_ 2_

_8_

Self-help (n=lO)
TOTAL Cn=30)

8 (26. 7%)

22

(73. 3%)

Table 4.9
Frequency Distribution of Smoking Cessation Outcome by
Treatment for the COPD Group.
Non-smokers

Smokers

Individual (n=lO)

3

7

Group (n=lO)

2

8

_ 1_

_9_

Self-help (n=lO)
TOTAL Cn=30l

6

(20%)

24

(80%)

Hypothesis 4:
There will be no relationship between demographic
variables and smoking cessation outcome between groups.
Hypothesis 5:
There will be no relationship between tobacco
dependency and smoking cessation outcome between groups.
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Hypothesis

6:

There will be no relationship between
smoking cessation outcome between groups.
Hypotheses
analysis.

4,

showed that no combination

overall

self-efficacy

scores,

duration

of smoking,

pack-year

baseline

smoking

freedom,

of grouped

tobacco

lambda was

classified

scores,

those who would
(With 5 degrees

The percent

of grouped

cases

See Appendix

of self-efficacy

7:

A discriminant

3)

symptoms:

frustration

concentrating
analysis

for comparisons

4)

1)

anger,

and 7)

nicotine
5)

craving,

anxiety,

restlessness.

6)

in combination

at the p=.05

two groups,

level,

2)

cessation

among normal

on seven smoking

cessation

irritability,

difficulty

The discriminant

showed that only two variables

restlessness)
outcome

analysis

and COPD were performed

withdrawal

and

by group.

There will be no relationship between smoking
withdrawal symptoms and outcome between groups.

smokers

of

as a smoker using

was 71.4%.

deviations

of

and pre-study

The percent

as non-smoker

and standard

dependency

Hypothesis

history

.856 and p=.1249).

was 69.6%.

classified

I for means

dependency

rate could differentiate

cases correctly

these variables
correctly

tobacco

from those who would not.

Wilk's

and

5, and 6 were tested using a discriminant

The analysis

quit smoking

self-efficacy

(anxiety and

could predict
(p=.0279).

smokers with COPD had higher

smoking

cessation

When comparing
anxiety

(2.067

the

±
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1.163 vs 0.889 ±0.832)

and higher

restlessness

0.990 vs 1.000 ± 0.970) than non-smokers
See Appendix

J

{2.533 ±

during

the program.

for means and standard deviations of the

withdrawal symptoms by group.
Attrition
In this study, attrition was a major influencing
factor.

While all post-test carbon monoxide measures were

obtained either at the time of discontinuation or at the
completion of the study, it is interesting to note the
attrition rate in Table 4.10.
Table 4.10
A Comparison of Weekly Attrition Rates Between Normal
Smokers, COPD and Individual, Group Therapy.
Group

Treatment

{n=30)

{n=30)

(n=20)

Normal Smokers

COPD

Individual

Visit 2

10.0%

23.3%

10.0%

40.0%

Visit 3

6.7%

6.7%

10.0%

10.0%

Visit 4

16.7%

10.0%

40.0%

TOTAL

3~s4l

40.0l

60.0l

(n=20)
Group

~

50.0l

Table 4.10 shows the weekly attrition rates by group
and by treatment respectively.

While the comparison of

total attrition percentages in the table appear to be
similar, it is interesting to note the large dropout rate at
Visit 2 in both the COPD group and Group treatment.

Thus,
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Group therapy experienced a large initial drop in
membership.

In this study, smokers with COPD and members of

Group therapy were most likely to discontinue early.
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CHA.Pl'ER FIVE

DISCUSSION AND SUMMARY
Summary
The present study randomly assigned normal smokers and
smokers with COPD to one of three smoking cessation
treatments.

The following is a discussion and summary of

the findings:
This study showed significant mean decreases in both
the number of cigarettes smoked and carbon monoxide levels
for all subjects in the program.

Twenty-seven percent

(8/30) of the subjects in the normal smokers group
successfully quit smoking.

In contrast, 20% (6/30) in the

COPD group were able to quit.

These results are consistent

with current nonpharmacological smoking cessation programs.
The assumption of the investigator that there would be
a difference between normal smokers and smokers with COPD
was not supported.

The two groups had roughly the same quit

rates, however in number of cigarettes smoked, there was a
significant group difference pre-test to post-test.

Normal

smokers were able to reduce the number of cigarettes smoked
more noticeably than the COPD group.

Based on the

understanding of the review of the literature, a larger
effect was expected.

This chapter focuses on some possible

explanations that could explain these results.
In discussing program evaluation, Green (1980) talks
about sleeper effects.

He suggests that health educators
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often do not put enough effort into health education
programs.

If it is lifestyle change that we're after,

health education programs may get the process started but
because measurements may be poor or infrequent, we don't
realize the trend is going on and we only measure it at a
couple points in time.

Even though an effect is not

established at the end of the program, indeed it may happen
later on.

Too frequently, we pull out before we can

actually see what has happened.
There are two ways to explain the results of this
study:

1) It is possible that there was an effect but it

was not capable of being measured based on:

the right

instrument was not used, the effect was not measured with
enough precision, the effect was not measured often enough
or over a long enough period of time.
is

The other explanation

2) there was not an effect, given the situation, given

the subjects, in that environment with that intervention
that there was not a difference between those conditions.
Discussion of Group Effects
It was disappointing that none of the demographic
variables, tobacco dependency scores or self-efficacy scores
were able to predict smoking cessation outcome, within the
groups.

With such small samples, a few extreme scores could

have skewed the results.

It is possible that if a larger

sample would have been used that a greater group
relationship may have been established.

For this study,

71
however,
largely

the two groups
the same.

were generally

(normal smokers and COPD) were

While the mean values

higher

for the COPD patient,

smoked about the same number
about the same pack-year

of cigarettes

history

had about the same pre-study
only difference

between

It is apparent

subjects

were more homogeneous

planned.

A more heterogeneous

a large

may have provided

homogeneity

of smoking
levels.

and

The

cough at least for two years
from the data that all 60

than the investigator

had

group with a wider variety

for a better

This finding

expression

of the

group.

rate, probably

Group therapy

had

due to the

of the group.

The investigator

believes

that there were differences

among the two groups but that they were not measured.
Instead

these differences

observation.

were based on personal

If we look at number

of self-reported

cigarettes

smoked and carbon monoxide

surprising

that these values

readings,

are somewhat

would tend to support that self-report

and physiological

will come out fairly close together.

if people

are giving a voluntary

based on a chronic

it is

identical--which

functions

patient

of

also colors the effect of the

in each treatment

initial dropout

had

these two groups was the subjective

in the COPD group.

type of smokers

at baseline,

carbon monoxide

productive

group effect.

both groups

and duration

claim of a chronic,

smokers

for each variable

definition

Therefore,

of a COPD

cough, then we best accept

it.
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But to say that the subjects who have symptomatic complaints
are the same as a group of people who don't profess to have
a chronic cough is ridiculous.

A possible way to create

larger differences between groups, was to have included
spirometrical criteria for eligibility criteria so as to
further define COPD patients with loss of lung function.
For some reason, these groups looked a great deal alike, but
one of them was obviously different because they were
reporting that they were coughing all the time and the other
group was not.
The overall attrition rate was 37% in this smoking
cessation program, however both normal smokers and COPD had
approximately the same percentages.

Some smoking cessation

programs in the literature use a commitment fee or a deposit
to increase program adherence.

This research did not use

this strategy, although if used, it may have had an effect
on the attrition rate and should be considered for future
studies.

Given that cigarette smoking is a highly

refractory behavior, the attrition rate is not surprising.
As the program evolved, though, it was fascinating to watch
the drop-out rate and listen to the various reasons for
discontinuing the program.

This was especially interesting

in the COPD group where 40% of the participants discontinued
by Visit 2.

This high early attrition rate in this group

could be due to the fact that these smokers are more highly
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addicted, smoked for a longer number of years and had more
previous smoking cessation attempts.
We should remember that the smokers in the COPD group
were experienced.

After a number of attempts at quitting,

they could tell within the first week if this attempt was
going to be successful.

All of those participants who

dropped out at Visit 2 had already gone back to smoking.
Perhaps the environment was not right for them to quit
smoking at this time.

This could be explained in terms of

Bandura's outcome expectation.

Most smokers will say that

they can quit if given the right circumstances.

Once they

get into a program and begin believing that, for various
reasons, the time is not right for them to quit, damage to
their outcome expectations may already occur.

In this

scenario, self-efficacy expectations may not be as important
as outcome expectations which can change just as rapidly as
self-efficacy.
The major reasons for discontinuation was the fear of
talking about smoking within a group situation.

This did

not seem to be a major factor with the participants in
individual therapy.

Perhaps this is an example of the way

illness behavior influenced this study.

For example,

perhaps patients with COPD have a narrow range within which
they can tolerate anxiety, and these patients may be unable
to tolerate the emotional stress caused by group
discussions.

However, these patients may be able to
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tolerate carefully

managed

with COPD who have socially

individual counselling.
isolated themselves

to their illness may be extremely uncomfortable
about their smoking cessation

efforts

The social unease and stiffness
acquainted,

Patients

in response
in talking

(Dudley et al. 1985).

that accompanies

not knowing what to expect,

getting

feeling a great deal

of anxiety is an undue source of tension in these patients.
Since both normal smokers and smokers with COPD were members
of the same group and expected to interact together,
could be that subjects
group of asymptomatic

it

labelled as COPD and thrown into a
smokers were thinking,

know what it is like to be like me.11

"They don't

If we think about

group anxiety and COPD in terms of the Health Belief Model
and its relation to chronic illness (Kasl, 1974), no amount
of susceptibility, seriousness or perceived benefits may be
able to overcome these barriers to achieve behavior change.
Group dynamics are an integral part of any group
smoking cessation therapy.

Understanding group behavior in

secondary groups (groups that are task-oriented) is
necessary for promoting cohesiveness with in the group.
Cohesiveness refers to how strongly members want to remain a
part of the group and comply with group norms (Bormann,
1975).

Researchers have shown that groups high in

cohesiveness have greater rates of interaction and have less
attrition (Brilhart, 1986).

For this reason, smoking

cessation within primary groups, such as work groups and
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families are thought to be more effective than participants
who are unfamiliar to each other.
Discussion of Measures
The Confidence Self-efficacy questionnaire and the
Fagerstrom Tobacco Dependence questionnaire demonstrated no
predictive validity.

In this study, tobacco dependency and

self-efficacy scores were not predictive of outcome.

Due to

the high standard deviations of these values, it appeared
that these measures had little more than face validity.
With regard to the self-efficacy effect, implications
for medical management are that the health care professional
should have some means of interpreting how a patient
perceives himself/herself to optimize behavior changes.

For

example, if the subject had low self-efficacy scores, then
the health care professional must look for ways to improve
the subjects' self-efficacy before beginning a smoking
cessation program.

Self-efficacy training is a tremendous

opportunity for health educators.

Without self-efficacy

training, we may be setting smokers up for failure because
we have not prepared them well.
Discussion of Health Effects
Many patients who did not give up cigarettes completely
reported substantial reductions in the amount smoked.

Time

effects for both mean carbon monoxide levels and mean number
of cigarettes smoked were seen indicating significant
reduction pre-test to post-test.

From the perspective of
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preventive medicine, reductions of this magnitude may
represent significant levels of impact in the health of all
patients (Windsor et al. 1980).

Statistical significance

and practical significance are not always the same thing.
One issue is that getting smokers to reduce the amount
that they smoke may not all be beneficial to their health,
but it is beneficial if they are serious about it as being a
step in the process of quitting.

If we can get their

addiction levels down to the point where there are not a lot
of physiological problems along with the psychological
problems of quitting, then a stepwise approach is clearly
worth investigating.

Almost all of the self-help books

discuss the various strategies for quitting.

These

strategies include cold turkey and also two methods of
reducing cigarettes as a means to stop.
are 1) tapering and 2) postponing.

These two methods

Tapering simply means

cutting down the total number of cigarettes each day until
Quit Day and postponing is waiting until a progressively
later time each day to have a cigarette until Quit Day.
Let's look at the carbon monoxide (CO) data in terms of
clinical significance.

It is known that as blood

carboxyhemoglobin (COHb) levels increase, health effects
become more severe (U.S. Environmental Protection Agency,
1979).

Heart and lung functional changes are associated

with COHb levels greater than 5%, which corresponds to
approximately 27 PPM

co

in exhaled air.

In the present
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study, the group means are well above this level before
treatment and consistently below at the end of treatment and
at follow-up and therefore demonstrates practical
significance.

The weekly feedback of co levels in the

individual and group therapy, which may have provided early
evidence of success, was commented on as being helpful by
the members of the individual and group therapy.
It was observed that several of the subjects reported
having lost or misplaced some of the diary cards.

There

were no discrepancies between self-reported number of
cigarettes smoked and carbon monoxide levels.

Therefore,

self-report on the diary cards are assumed to be reasonably
valid indicators of actual behavior in this sample.
The fact that individual and group therapy were
significant over self-help therapy justifies the expense of
inputs into an intensive smoking cessation program.

Staff

time, resources and training materials can be significant
items of expense in any program.

In this study, it was

shown that such an expense was worthwhile in being able to
change smoking behavior.
This study employed smokers that were voluntarily
asking to become quitters.

Even the self-help treatment

group showed some success, although not much.

However,

self-help interventions may still be justified on a
cost-effective basis for some smokers (Glasgow et al. 1981).
It is true that the Self-help group did not do as well as
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Individual or Group therapy, but we should not expect much
success given that it is an inexpensive treatment.

However,

smoking is an important and expensive health problem.

Even

small steps toward solving the problem can be beneficial.
From this standpoint, one might begin with a
self-administered program, and follow with a more complex,
multicomponent behavior therapy program administered by a
therapist.
Limitations of the Study
These results must be seen as specific for this
population and interpreted with caution.

Limitations

include the small number of subjects, lack of control and
the absence of even longer follow-up data.

Although the

present study was useful in recruiting participants,
attrition rates are high and outcome modest.

The cell sizes

were quite small and thus the reader is cautioned about
overgeneralizing from the results.
This study shares limitations with other evaluations of
smoking cessation programs.

To study users of a program

effectively, experimental contact should have been provided
beyond the program alone (6 week, 2 months, 3 months, 6
months, 1 year).

Follow-up was not included in this study.

As much as one can control for nuisance variables, no
experimental treatment is exactly alike for every subject in
a particular condition.

Environmental changes such as

temperature, noise level, interruptions and inconsistent
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performance of the smoking cessation therapist are all
possible variables that may have affected this study.

All

attempts were made to control as many confounding variables
as possible.

Under normal conditions, it was expected that

extraneous variables would operate equally.
One of the largest threats to internal validity in this
study was experimental mortality.

Every effort made to

emphasize the importance of continuing all sessions in an
attempt to reduce attrition.

Subjects were encouraged to

continue therapy sessions even if they had smoked with the
hope that they would quit yet before all sessions were
completed.

If subjects did not return for their post-test

carbon monoxide levels, the post-test number of cigarettes
smoked was obtained by self-report, either verbally or by
diary.

For those subjects who did drop out of therapy, the

number, type of group the subject was in and the reason for
discontinuation were all recorded.
The investigation was limited only to twenty subjects
in each treatment group and ten in each cell because of lack
of funding and personnel.

However, this sample was believed

to be large enough from which to draw conclusions, or at
best, trends.
All therapy sessions were conducted by the principal
investigator so that inter-investigator training for smoking
cessation therapy was not needed.

In addition, the

investigator attempted to refrain from displaying any study
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expectancies.

The American Cancer Society's FreshStart

Facilitator's Guide was used as the investigator's manual to
ensure uniform counseling.

Of the measures of the dependent

variable, only number of cigarettes smoked since Quit Day
and withdrawal symptoms were self-reported on the diary
cards.

Exhaled carbon monoxide is a physiological test of

smoking cessation.

Therefore, because there was no

observational recording of the dependent variable in this
study, there was not an opportunity for observer bias to
occur.
The investigator was disappointed in the value of the
demographic questionnaire.

It became evident that important

information was not included and the investigator had to ask
each and every subject for continuous data on the daily
number of baseline cigarettes (the questionnaire asks for
categorical data) and the duration of a self-proclaimed
productive cough.

Retrospectively, interesting information

such as number of previous quit smoking attempts could have
been obtained and analyzed to see if that might have had an
effect on outcome between the two groups.
Other information that could have provided a stronger
study would have been to obtain a baseline diary one week
before Quit Day to objectively report the daily baseline
number of cigarettes smoked rather than pure verbal
self-report.
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As previously
ethical

mentioned,

issues involving

any of the participants

other limitations

the self-help

who were still smoking

the study were offered treatment
experiment

was concluded.

"internal"

replication

subjects

This was thought

with itself

the treatment).

investigator
treatment

believes

period,

the program

struggle

an

(before and after
none of the

forms of therapy.

were genuinely

The

motivated

and

to follow program principles.

was over, however,

of remembering

to provide

that during the four weeks of the

subjects

tried very diligently

at the end of

as the self-help

Unfortunately,

asked for alternate

Therefore,

of their choice after the

of the experiment

group could be compared
receiving

group.

included

it appeared

not to have a cigarette

with temptation

After

that the stress

and the constant

was too much to bear.

It didn't

seem to be the fact that they didn't want to quit again but
just that they needed
experience
damaged

"a break."

of their attempt

collected
quitting

program

beyond

right away.

the point of readiness

Again, useful

data to have

would have been the total number of attempts

at

to see if this may have correlated.

Although

one might wish to generalize

this study to "all" smokers,
generalize
addition,

their too-recent

to quit smoking and failure

their self-efficacy

for another

Perhaps,

only from which
various

strictly

the findings

speaking

we can

the sample was drawn.

personological

variables

of

In

may affect the
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generalizability of findings from this experiment--further
classification of gender, extroversion-introversion, locus
of control and illness behavior as well as many other
factors characterizing smokers could have affected the
results of this study.

This study attempted to control for

initial differences by incorporating control factors in the
statistical analysis.

Self-efficacy and tobacco dependency

were tested using homogeneity of regression for their
utility as covariates.
supported.

Homogeneity of regression was not

Thus, the two groups were heterogenous with

regard to these factors.
One threat to internal validity in this study is the
unreliability of the measures (self-efficacy scores and
tobacco dependency scores) which were to be used as
covariates to control for initial differences between
groups.

One possible explanation for the lack of

homogeneity for these two variables is the tests used to
measure tobacco dependency and self-efficacy.

A good

instrument is one that differentiates between subjects.

The

usefulness of a questionnaire depends on its
responsiveness--that is, its ability to detect clinically
important changes, even if the changes are small (Guyatt et
al. 1985).

Because "construct validity" was unable to be

used due to lack of a comparable standard for self-efficacy,
"face validity" was relied upon.

Better development of

self-efficacy measures in the future may provide for more
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predictive validity.

As for tobacco dependency, past

research has indicated that the Fagerstrom Tobacco
Dependence questionnaire does have predictive capabilities.
In this study, tobacco dependency scores were the closest to
significance than any of the other variables used in the
discriminate analysis.

Therefore, one can probably dismiss

the lack of predictive validity for tobacco dependency
scores as due to sampling error.

The sample may have been

too small, there may have been a few erratic scores and the
standard deviations were too wide that the tobacco
dependency score was unable to predict.
Future Research
Future research should address the types of smokers who
are likely to be attracted to alternative, potentially
cost-effective approaches.

Future research is still needed

in developing effective smoking cessation programs for
smokers dealing with cigarette-related chronic illnesses.

A

study using pharmacological therapy such as the Nicorette
gum would be beneficial in smokers with COPD.
behavior is a complex medical phenomenon.

Illness

As we develop

programs for those already diagnosed with an illness, we
need to think about the effect that illness behavior may
have on the program.
in illness is needed.

Further characterization of behavior
It may be of value for researchers in

smoking cessation to study how group cohesiveness can be
fostered.

Future research is also needed to understand the
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nature of adherence rates in self-administered programs
(Glasgow et al. 1981).

Clearly, additional research in all

these areas are strongly warranted.
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~University
~of
Nebraska

Office of the Executive Secretary, IRB

5017 Conkllng Hall
University of Nebraska Medlcal Center
·
42nd & Dewey Avenue
Omaha, NE 68105
(402) 559-6463

The Uftlvo11llyol Ntbt11k1
ln1llluUOt11I A..,11w 8011d
fOf lht Prot1cuon of
Hum1n lub)1cl1

January 30, 1990

Mary Mueller, PA-C
Cary Martin, Ph.D.
HPER

UHL

REr
TITLE

IRB I 262-90
OF PROPOSAL1

__ A~C"""'"om"""'pa~r=i=s~o~n---o_.f_.S ....mo..._..k_.i'"'n""g....._.C:..:e:..:s..-s:..:a:..:t:..:i:..:o"'n"""""M'"'e:..:t'"'h'"'o:..:d..-s~i:..;.n;.....;.N""o:..:r..-m:;.;:a:..:l;.....;:S;.;;m:;.;:o:..:.k;..:e:..:r:..:11:..

and Smokers with Chronic Obstructive

Pulmonary Disease

Dear Ms. Mueller and Dr. Martin:
The Institutional Review Board tor the Protection ot Hwnan Subjects has completed
it• review ot your proposal, includin9 any revised material submitted in reeponse
to our request, and has expressed it as their opinion that you have provided adequate safeguards for the rights and welfare of the subject• to be involved in this
study and has, therefore, recommended
your project for approval.
This letter constitutes official notification ot the approval and release of your project by our
Board, and you are therefore authorized
to implement this study accordingly,
We wiah to remind you that, under the provisions ot the General Aaaurance from the
University o! Nebraska to DHHS on the Protection of Human Subjects, the principal
investi9ator or project director is directly responsible for keeping this Board
informed ot any changes involvin9 risks to the subject• or others.
This project
is subject to periodic review and surveillance by the Board, and, as part of their
aurveillance, the Board may request periodic reports of progress and results.
For
projects which continue beyond one year from the atartin9 date, it is also the
responsibility of the principal inveatigator to initiate a request to the Board
for annual review and update o! the research project.

h.o.
Secretary,

IRB

EDP/lme
Unlverally of Hebruk1-Llncotn

Vnl•erally ol Neb111k111 Om1h1

Vnl•er111yol Netwuk1 Medlc11Center
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OMAHA, NEBRASKA, FEB . .f, 1990
SECTION B-18 PAGES

SMOKERS
19 yrs. of age or older
needed to participate in
a stop srnoklnqstudy,
For more
information
call

559·6868

\t\~
~~~

a

t't\er

University
of Nebraska
Medical Center
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APPENDIX C

Sdlool of H11tth,
Physic.I Education ind Recrutlon
Uncotn, NE &8588-0229

University of
Nebraska
Lincoln
CONSENT FORM

A COMPARISON OF SMOKING CESSATION METHODS IN NORMAL SMOKERS AND
SMOKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Invitation To Participate
We invite you to participate in a research study comparin9
the e!!ectiveness o! three smokin9 cessation treatment methods.
Basis For Sub1ect Selection
You have been selected to participate in this study because
you are a cigarette smoker, over 19 years of age, who is ready to
stop smoking. No other forms of tobacco or nicotine other than
cigarettes will be allowed. There will be 60 participants
enrolled in this study.
Purpose Of The Study
The purpose of this study is to compare the e!!ectiveness o!
three types o! smoking cessation methods in di!!erent types of
smokers.
Explanation Of Procedures
This study will take !our weeks to complete. The !ollowin9
are the procedures you will undergo as a subject in this study:
Study Visit 1
You will be randomly assigned (similar to !lippin9 a coin)
to one of three treatment groups: 1) individual therapy; 2)
group therapy; or, 3) given only the manual and asked to return
at the end o! the study. Visit 1 will require 30 minutes. To
confirm your smoking history, you will be asked to complete some
questionnaires and provide a sample o! expired air (for assessing
carbon monoxide levels). There will be three questionnaires.
One questionnaire will give us some basic information about you,
your smoking history and your lung status. Another will give us
an idea of how dependent you are on nicotine. The last
questionnaire describes situations where people frequently smoke.
Subject's Initials

Unlveraltyof Nebraaka-uncoln

University of Nebruka at Omaha

U~ty

of Nebrukl Medical Cenlet

88

School of HH"h,
Physlcal Edl.Qtlon 1nd Recrutlon
Uncoln, NE 6858$-0229

University of
Nebraska
Lincoln

You will be asked to rate the probability to resist the urge to
smoke if the situation arises. Carbon monoxide is found in
cigarette smoke. In order to determine whether or not you are a
cigarette smoker, you will be asked to hold your breath for 20
seconds then exhale through a mouthpiece into the carbon monoxide
machine. At the end of this visit, you will be given a manual to
help support your quitting efforts. Your quit-smoking day will
be the next day, and you will be asked to quit entirely.
Study Visit 2-5
If you are assigned to individual or group therapy, you will
be asked to return weekly for four more counselling sessions.
Group therapy will take approximately one hour, and individual
therapy sessions will take about 30 minutes. You will be given
diary cards to keep track of withdrawal symptoms. At each of the
remaining visits, we will collect your diary cards, and you will
provide us with a sample of expired air to confirm your smoking
status. While participating in this study, you must refrain from
using any other form or method of smoking cessation. If you were
assigned to the self-help treatment method, you will be contacted
after !our weeks to determine whether or not you are smoking.
All subjects who are unsuccessful will be offered an alternate
therapy of their choice,
Potential Risks Alld Discomforts
There are side effects associated with quitting smoking.
These include headache, sleep disturbance, irritability, anxiety,
upset stomach, impaired concentration, frustration, depression
and weight gain.
Potential Benefits
You may not receive any direct benefit from participating in
this study. A potential benefit of participating in this study
is the possibility that you may stop smoking. However, we cannot
guarantee that the study will enable you to stop smoking. In
fact, regardless of the treatment you receive, you will still
have to try very hard in order to stop. Your efforts, however,
may lead to new methods for treating tobacco dependence.
Subject's Initials

Unlverwity of Nebr11b-Uncoln

Unlve,..lty of Nebruq 11 Omaha

89

a

School of HHnh,
Phyaleal Educallon and R~Hllon
Uncoln, NE NMa-02211

University of
Nebraska

Lincoln

Alternatives To Participation
Alternative and partially effective ways to treat tobacco
addiction already exist. These alternatives, dependinq upon your
physician's recommendation, may include formalized atop-smokinq
pro9rams or stoppinq cold-turkey.
Financial Obligations
There are no financial obli9ations to you for participatinq
in this study,
Compensation for Participation
There are no economic incentives or extrinsic rewards for
participation in this study. It is hoped that a successful
attempt at smoking cessation will be its own reward.
Assurance Of Confidentiality
Any information obtained durinq this study which could
identify you will be kept strictly confidential. The information
obtained in this study may be published in scientific journals or
presented at scientific meetinqs, but your identity will be kept
strictly confidential.
Withdrawal from The Study
Participation is voluntary. Your decision whether or not to
participate will not affect your present or future relationship
at the University of Nebraska. If you decide to participate, you
are free to withdraw from this study at any time.
If any new information develops durinq the course of this
study that may affect your willinqness to continue participatinq,
you will be informed immediately.
Offer To hoswer Questions
If you have any questions, please do not hesitate to ask,
and they will be answered at this time. If you think of any
additional questions later, please feel free to contact one of
the investiqators listed below.
Subject's Initials

University of Nebrask~n

Unlve1111y of Nebteak•

at Omaha

Unlv..wlty

of Nebt Hka Medlcal Cent et

90

School ol Health,
Phyeical Education and Recreallon
l.Jncx>ln, NE 68!>88·0229

University of
Nebraska
Lincoln

If you have any questions concerninq your ri9ht1 ••a research
subject, you may contact the University o! Nebraaka Institutional
Review Board (IRB), telephone 402/559-6463.
YOU ARE VOLUNTARILY MAKING A DECISION WHETHER OR NOT TO
PARTICIPATE IN THIS RESEARCH STUDY. YOUR SIGNATURE CERTIFIES
THAT YOU HAVE DECIDED TO PARTICIPATE HAVING READ AND UNDERSTOOD
THE INFORMATION PRESENTED. YOUR SIGNATURE ALSO CERTIFIES THAT
YOU HAVE HAD AN ADEQUATE OPPORTUNITY TO DISCUSS THIS STUDY WITH
THE INVESTIGATOR, AND YOU HAVE HAD ALL YOUR QUESTIONS ANSWERED TO
YOUR SATISFACTION. YOU WILL BE GIVEN A COPY OF THIS CONSENT FORM
TO J<EEP.

Date

Signature of Subject

HY SIGNATURE AS WITNESS CERTIFIES THAT THE SUBJECT SIGNED THIS
CONSENT FORM IN HY PRESENCE AS HIS/HER VOLUNTARY ACT AND DEED.

Date

Signature of Witness

IN MY JUDGEMENT, THE SUBJECT IS VOLUNTARILY AND KNOWINGLY GIVING
INFORMED CONSENT AND POSSESSES THE LEGAL CAPACITY TO GIVE
INFORMED CONSENT TO PARTICIPATE IN THIS RESEARCH STUDY.

Date

Signature of Investigator
Investigators:
Mary Mueller, PA-C
Gary Hartin, Ph.D.

559-7555
472-1728

(day)
(day)

Unlv•r•lly ol N•bf.,k• •I Omaha

391-4790
477-3138

(night)
(night)
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APPENDIX E

Study Case Number:
Participant's Initials:
DEMOGRAPHIC PULMONARY ASSESSMENT PROFILE
Dear Participant:
Please answer the following questions as they pertain to your
general health:
1.

What.is your age?

2.

Are you:

3.

Do you currently smoke:

Hale

Female

Less than 1/2 pack per day

1/2 to 1 pack per day

1-2 packs per day

Over 2 packs per day

Current brand:
4.

Total years smoked in all?

5.

Do you have an intermittent cough
(not related to a common cold)?

Yes

No

6.

Do you frequently cough in the morning?

Yes

No

7.

Is y~ur cough related to mucus in
your chest or throat?

Yes

No

Do you experience intermittent
chest congestion?

Yes

No

9.

Oo you have shortness of breath?

Yes

No

10.

I! yes, when?

8.

During strenuous exercise
During normal activity

years

~-During moderate exercise
While at rest
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APPENDIX F

SMOKING .HISTORY
THE FAGERSTROM NICOTINE
TOLERANCE SCALE

SCN:

PATIENT INITIALS:

PLEASE CIRCLE THE APPROPRIATE

A (0)

RESPONSE

1,

HOW SOON AF"TER YOU WAKE UP DO YOU
SMOKE YOUR rlRST CIGARETTE?

2.

DO YOU rlNO IT DIFTICUL T TO RErRAIN
FROM SMOKING IN PL.ACES WHERE IT IS
f"ORBIOD(N, SUCH AS THE LIBRARY,
THEATER, DOCTOR'S orncE?

3.

WHICH or ALL THE CIGARETTES YOU SMOKE
IN A DAY IS TH( MOST SATISF"YING ON(?

'·

HOW "4ANY CIGARETTES A DAY 00 YOU
SMOKE:?

5.

An[R

30 MIN

B (1)

(2)

---

WITHIN 30 MIN

NO

ANY OTHER
THAN TH(
rlRST ON( IN
THC l.IORNINC

c

YES

TH( rlRST ONE
IN TH(
MORN IN()

--

1-15

16-25

MORE
THAN 25

00 YOU SMOKE "40RE DURING THE MORNING
THAN DURING THE REST or THE DAY?

NO

YES

--

6.

00 YOU SMOKE WHEN YOU ARE SO ILL
THAT YOU ARE IN BED MOST or THE DAY?

NO

YES

--·

7.

DOES THE BRANO YOU SMOKE HAV( A L6W,
MEDIUM, OR HIGH NICOTINE CONTENT?

LOW

8.

HOW orrr«
DO YOU INHALE THE S"40KE
rROM YOUR CIGAREnE?

(0 ..... 00 ""'

N[V(R

MEDIUM
co•• ... - ·~1

HI~

CWC\"

':f"

ALWAYS

SOMETIMES

ASSIGN NO POINTS f"OR EACH ANSWER IN COLUl.AN A. 1 POINT f"OR EACH ANSWER IN
COLUMN B. ANO 2 POINTS rOR EACH ANSWJR IN COLUl.AN C (NOTE THAT NOT ALL
OUESTIONS HAVE AN ANSWER IN COLUMN c . TH[N, TOTAL TH[ NUMBER or POINTS
TO ARRIVE AT THE rACERSTROM SCOR(:. T E HIGHEST POSSIBLE SCORE IS 11.

I

TOTAL SCORE:

I
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APPENDIX G

SCORING OF FAGERSTROM TOBACCO DEPENDENCE QUESTIONNAIRE
Each completed Fagerstrom Tobacco Dependence Questtonnatre ts to be scored
using the following technique.
Questions 1 and 2 are to determine the subject's brand and type of cigarette.
The nicotine content (tn milligrams per cigarette) ts obtained from the most
recent listing of the Federal Trade Commtsston Report. Refer to the following
pages for the Nicotine Content listing. The scoring of nicotine content ts as
follows:
·
Low(< 0.6 mg ntcotlne/ctgarette) • O
Moderate (0.6 · I.I mg nicotine/cigarette)• I
High (> I.I mg nicotine/cigarette)• 2
The scoring of other questions Is as follows:
Question 3:

within 1/2 hour• I
over I/2 hour • 0

Question 4:

Ho • O
Yes• I

Question 5:

the first cigarette tn the morning• I
other• 0

Question 6:

Ho • 0
Yes•

Question 7:

Ho • 0
Yes• I

Question 8:

Never• 0
Sometimes•
Always• 2

Question 9:

Less than lS • 0
I6. 25. I
More than 26 • 2

Enter the score for each question tn the "Completed by the Investigator Only"
section on the right side of the questionnaire. Total the score of each ques·
tlon to get the total Fagerstrom Tobacco Dependence score.
A total score of Q..=~ (Inclusive) Indicates low nicotine dependence.

A total score

or~

(Inclusive) Indicates high nicotine dependence.
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Nicotine Content of Two Hundred Eleven Varieties of Domestic Cigarettes
(Adapted from the Federal Trade COlll!llsslon Report)
BRAND TESTED
ALPINE
BARCLAY IOO
BELAIR
BELAIR IOO
BENSON & HEDGES
BENSON & HEDGES
BENSON & HEDGES JOO
BENSON & HEDGES JOO
BENSON & HEDGES IOO
BENSON l HEDGES 100
BENSON & HEDGES LIGHTS IOO
BENSON & HEDGES LIGHTS 100
BENSON & HEDGES ULTRA LIGHTS
BENSON & HEDGES ULTRA LIGHTS
BRIGHT
BRIGHT 100
BULL DURHAM
CAMBRIDGE
CAMBRIDGE
CAMBRIDGE IOO
CAMEL
CAMEL
CAMEL
CAMEL LIGHTS
CAMEL LIGHTS
CAMEL LIGHTS IOO
CAPRI LIGHTS
CARLTON
CARLTON
CARLTON
CARLTON JOO
CARLTON IOO
CARLTON JOO
CARLTON 100
CARLTON J20
CARLTON IZO
CENTURY
CENTURY LIGHTS
CHES TE RF I ELD
CHESTERFIELD
DO RADON
DORAL II
DORAL II

TYPE CODE

NICOTINE CONTENT

F: SP: H
F
F: SP: H
F: SP: H
R: F: HP
F : HP
F : HP
F: HP: H
F : SP
F: SP: H
F : SP
F : SP: H
F : HP
F HP: H
F .SP : H
F SP: H
F : SP
F: HP
F SP
F SP
R.: NF SP
F HP
F SP
F HP
F SP
F SP
F.
F HP
F : SP
F SP: H
F : HP
F HP: H
F : SP
F SP: H
F : SP
F SP : H
F SP
F SP
SP
R : HF
NF SP
F SP
F : SP
F : SP: H

0.95
0.40
0.74
0.6I
0.07
I. IO
I.OZ
I. 01
1.03
J.04
0.73
0. 70
0.40
0.42
0.52
0.52
1.83

•

0.08
0.44
1.40
1.08.
1.07
0.69
0.66
0.83
0.80
*
0.1 I
0.07
0.05
*
0.40
0.41
0.59
0.62
0.94
0.69
I. 22
I. 52
0.90
0.38
0.38

F·f11ter, NF•non·fllter, H•menthol, R•regular, HP•hard pack, SP·soft pack
*Below the sensitivity of the method (0.05 mg nicotine).
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Nicotine Content

or

Two Hundred Eleven Varieties or Domestic Cigarettes

(Adapted from the Federal Trade Conrnlsslon Report)

ENGLISH OVALS
ENGLISH OVALS
EVE LIGHTS 100
EVE UGHTS 100

EVE LIGHTS 100
120
GALAXY
GENERIC ULTRA LIGHTS
HALF & HALF
HERBERT TAREYTON
ICEBERG JOO
EVE LIGHTS

R : NF : HP
HF : HP

F: HP
F: HP: H
F: HP
F :: HP : H
F: SP
F: SP
NF: SP

.F

SP : H

F : HP
F ·SP
F ; SP

KENT

KENT
KENT 100
KENT 100
KENT GOLOEN LIGHTS
KENT GOLDEN LIGHTS
KENT GOLDEN LIGHTS 100
KENT GOLDEN LIGHTS JOO
KENT II I
KENT Ill JOO
KOOL
KOOL
KOOL
KOOL LIGHTS
KOOL LIGHTS 100
KOOL f'llLDS
KOOL MILDS 100
KOOL SUPER LONGS 100
KOOL ULTRA '
KOOL ULTRA JOO
L
L

&

H

& H
l & H 100
L & H LIGHTS
l & H LIGHTS 100
LARK
LARK 100
LARK LIGHTS
LARK lJGHTS 100
LUCKY STRIKE
LUCKY STRIKE
LUCKY STRIKE
LUCKY STRIKE JOO

F

SP : H

F : SP
SP : H
F: SP
F : SP : H
F: SP
F: SP
F

R: NF : SP : H
F : HP: H

F
F
F
F
F

:
:
:
:
:

SP: H
SP: H
SP : H
SP: H
SP : H
f : SP : H
F : SP : H
F : SP : H
F: HP

F: SP

f :

F:
F:
F:
F :

SP
SP
SP
SP
SP

F: SP
F:
R: HF:
F:
F :
F:

SP
SP

J. 75
2 .10

0.93
0.94
1.08
1.06

0.89
0.48
). 28
J .50
0.31
0.87

0.91
J.01
I.ZS
0. 75

0.69
0.84

0.79
0.29

0.4Z
I. 23
J.06

1.04

0.65
0.70
0.73
0.82
0.88

0.13
0.38

0.9Z
0.91
0.98
0.74
0.83
0.92

0.99
0.89
0.97

HP

1.37
0.77

SP

0.80

SP

0.86

F•fllter, NF•non·fllter, H•menthol, R•regular, HP•hard pack, SP•soft pack
•Below the sensttlvtty of the method (0.05 mg nicotine).
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Nicotine Content of Two Hundred Eleven Varieties of Domestic Cigarettes
(Adapted from the Federal Trade Conmlsslon Report)
MARLBORO
MARLBORO
MARLBORO
MARLBORO 100
MARLBORO 100
MARLBORO LIGHTS
MARLBORO LIGHTS
MARLBORO LIGHTS 100
MAX 120
MAX 120
MERIT
MERIT
MERIT 100
MERIT 100
MERIT ULTRA LIGHTS
MERIT ULTRA LIGHTS
MERIT ULTRA LIGHTS 100
MERIT ULTRA LIGHTS 100
MONTCLAIR
HORE 120
HORE 120
HORE LIGHTS 100
HORE LIGHTS 100
MULTI FILTER
HULTIFILTER
NEWPORT
NEWPORT
NEWPORT 100
NEWPORT LIGHTS
NEWPORT LIGHTS
NEWPORT LIGHTS 100
NEWPORT RED
NEWPORT RED
NOW
NOW
NOW
NOW 100
NOW 100
NOW 100
OLD GOLD f IL TER
OLD GOLD FILTER 100
OLD GOLD LIGHTS
OLD GOLD STRAIGHT
PALL HALL
PALL HALL

F

F
F
F
F
F
F
F
F
F
f

F
F
f
f

F

F
f

F : HP
F : SP
SP : H
F HP
SP
F
F HP
F SP
F SP
F : SP
SP : H
F: SP
SP : H
F : SP
SP : M
F : SP
SP: H
F: SP
SP : H
SP : H
F : SP
SP : H
F : HP
HP : H
f : SP
SP : H
HP : H
SP: H
SP: H
HP : H
SP : H
SP : H
F : HP
F : SP
F : HP
F : SP
SP : H
f : HP
f : SP
SP : H
F SP
F : SP
F: SP
NF : SP
NF: SP
f: SP

0.97
1.00
0.96
1.05
I.OS

0.69
0.69
0.71
1. 40
1.44
0.52
0.54
0.71
0.67
0.38
0.37
0.43
0.35
0.98
1.19
1. 21
0.65
0.61

o. 77

0.76
1.14
1. Zl
1.46
o. 72
0.70
0.83
0.94
1.04

•

0. I I
0.09
0.07
0.27
O.Z4
I. ZS
I.SZ
0.82
1.62
1. 34
1.11

F•fllter, NF•non·fllter, M•menlhol, R•regular, HP·hard ~ack, SP•soft pack
•Below the sensitivity of the method (0.05 mg nlcotlne.
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Nicotine Content of Two Hundred Eleven Varfetles of Domestic Cigarettes
(Adapted from the Federal Trade Corrmlsston Report)
1.09
F: SP
PALL MALL 100
0.59
F: SP
PALL MALL EXlRA LIGHT
0.75
F: SP
PALL MALL LIGHT 100
0.97
F
SP : 11
PALL HALL LIGHT 100
0.61
F: HP
PARLIAMENT LIGHTS
0.63
F: SP
PARLIAMENT LIGHTS
0.83
F: SP
PARLIAMENT LIGHTS 100
J. 24
R: HF : SP
PHILIP MORRIS
1. 59
NF: SP
PHILIP MORRIS COMMANDER
J.07
F : HP
PHILIP MORRIS INTERNATIONAL 100
J.07
F: HP: H
PHILIP MORRIS INTERNATIONAL 100
J.00
R:
NF:
SP
PICAYUNE
J.90
R: NF: HP
PLAYERS
0.80
F: HP
PLAYERS
0.79
F: HP: H
PLAYERS
0.89
F: HP
PLAYERS 100
0.87
F: HP: H
PLAYERS 100
J.38
NF: SP
RALEIGH
0.89
F: SP
RALEIGH
l.04
F: SP
RALEIGH JOO
o. 76
F: SP
RALEIGH LIGHTS
0.69
F: SP
RALEIGH LIGHTS 100
I.OS
F: SP
RICHLAND
0.9S
F: SP: H
RlGHLANO
0.90
F : H
RITZ 100
J.06
F: SP: H
SALEH
I.
ZI
F
:
SP
:
H
SALEH 100
o. 70
F : SP : H
SALEH LIGHTS
0.74
F : SP : H
SALEH LIGHTS 100
0.66
F : HP : H
SALEH SLIM LIGHTS 100
0.43
F : SP : H
SALEH ULTRA
0.42
F: SP: H
SALEH ULTRA 100
0.94
F: HP
SARATOGA 120
0.93
F:
HP:
H
SARATOGA 120
0.85
F: SP
SATIN 100
0.82
F : SP : H
SATlH 100
0.88
F : SP
SILVA THINS 100
0.89
f : SP : H
SILVA THIHS 100
I.OS
f : SP : H
SPRING 100
I.OS
F: SP
ST. MORITZ 100
}.07
F : SP : H
ST. MORITZ 100
J.49
F: SP
TALL l ZO
1.29
F: SP: H
TALL 120
F·fllter, NF•non-fllter, M·menthol, R•regular, HP•hard pack, SP·soft pack
•Below the sensitivity of the method (O.OS mg nicotine).
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Nicotine Content of Two Hundred Eleven Varieties of Domestic Cigarettes
(Adapted from the Federal Trade Commission Report)
TAREYTON
TAREYTON JOO
TAR EYTON LIGHTS
TAREYTON LONG LIGHTS 100
TRIUMPH
TRIUMPH
TRIUMPH 100
TRIUMPH 100
TRUE
TRUE
TRUE 100
TRUE 100
VANTAGE
VANTAGE
VANTAGE JOO
VANTAGE JOO
VANTAGE ULTRA LIGHTS
VANTAGE ULTRA LIGHTS
VANTAGE ULTRA LIGHTS JOO
VANTAGE ULTRA LIGHTS JOO
VICEROY
VICEROY RICH LIGHTS
VICEROY RICH LIGHTS JOO
VICEROY SUPER LONG 100
VIRGINIA SLIMS JOO
VIRGINIA SLIMS 100
VIRGINIA SLIMS LIGHTS JOO
VIRGINIA SLIMS LIGHTS JOO
WINSTON
WINSTON
WINSTON 100
WINSTON INTERNATIONAL JOO
WINSTON LIGHTS
WINSTON LIGHTS JOO
WINSTON ULTRA LIGHTS
WINSTON ULTRA LIGHTS JOO

F SP
F SP
F SP
F SP
F: SP
F SP : H
F: SP
F SP: H
F : SP
F SP : H
F : SP
F SP : H
F : SP
F SP: M
F: SP
F: SP: HO
F : SP
F : SP: H
F: SP
F : SP : H
F: SP
F: SP
F : SP
F: SP
F : SP
F SP: H
F : HP
F HP : M
F : HP
F SP
F Sp
F HP
F SP
F SP
F : SP
F: SP

0.86
0.93
0.36
0.6Z
0.30
0.30
0.41
0.39
0.41
0.4Z
0.6Z

o.sa
0.71
0.67
0.71
0. 72
0.43
0.40
0.45
0.44
0.94
0.74
0.78
0.94
0.93
0.94
0.57
0.56
1.07
1.06
1.20
1.10
0.65
0.83
0.4Z
0.45

F•fllter, NF•non-fllter, M·menthol, R•regular, HP•hard pack, SP•soft pack
•Below the sensitivity of the method (0.05 mg nicotine).
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APPENDIX H

CONFIDENCE QUESTIONNAIRE
Initial8

Study

ea .. Humber

_

Belov is a list of 15 aituationa in which people frequently amoke.
Pleaee read each one carefully. Then circle the number underneath
which best describes 11fE PROBABILITY THAT YOU lo'ILL BE ABLE TO RESIST
11fE URGE TO SHOJ:E IM THAT SITUATION IN THE FUTURE IF TIIE SITUATION
ARISES. If you are absolutely certain that you will not smoke in that
situation, circle 100%. If you hava .!12. confidence in 7our ability to
resist a cigarette in that situation, circle 0%. Please aelect only
the percentagea and do not mark between the numbers. More likely,
your confidence will vary. For example, if you are pretty aure that
you vill be able to resist the urge to smoke if and vhen you vent to
relax, but not absolutely certain, you might circle 80%. If you are
pretty aura you vould .!!.,2S be able to~
a cigarette if that
aituation ariaes, but not absolutely aura you couldn't, you might
circle 20%.
1.

When you feel anxioua.
0% - 10% - 20% - 30% - 40% - SO% - 60% - 70% - 80% - 90% - 100%

2.

When you vent to eit back and enjoy a cigarette.
0% - 10% - 20% - 30% - 40% - ~% - 60% - 70% - 80% - 90% - 100%

3.

Whan you have finished a •eal or anack.
0% - 10% - 20% - 30% - 40% - SO% - 60% - 70% - 80% - 90% - 100%

4.

When you are nervous.
0% - 10% - 20% - 30% - 40% - SO% - 60% - 70% - 80% - 90% - 100%

S.

When you vent to feel more attractive.
0% - 10% - 20% - 30% - 40% - ~% - 60% - 70% - 80% - 90% - 100%

6.

When you vent to relax.
0% - 10% - 20% - 30% - 40% - SO% - 60% - 70% - 80% - 90% - 100%
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7.

When you feel smoking is part of your ealf-imaga.
0% - ·10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100%

8.

When you feel tense.
0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100%

9.

When you are drinking an alcoholic be•eraga.
0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100%

10.

\ihen

JOU

aee others smoking.

0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100%
11.

\ihen someone offers

JOU

a cigarette.

0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100%
12.

\ihen

JOU

vent to avoid eating sweets.

0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100%
13.

\ihen you want to feel more mature and sophisticated.
0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100%

14.

\ihen

JOU

vant to keep alim.

0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100%
15.

What ia tha probability that you will be ebla to re1iet the urge
to smoke altogether in the future, resardlaaa of the eituation?
0% - 10% - 20% - 30% - 40% - 50% - 60% - 70% - 80% - 90% - 100%
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Table

4.11

Means

and Standard

Dependency

peviations

I

of Self-efficacy

and Tobacco

by Group.
Group
Normal

COPD

Smokers

Cn=30)

Cn=30l
M
Self-efficacy
Tobacco Dependency

SP

55.467 14.438
6.400

1.714

M

SD

46.967 17.775
6.933

1.946
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J

Table 4.12
Means and Standard Deviations of Withdrawal Symptoms by
Group.
Group
Normal Smokers

COPD
(n=30)

Cn=30)
M

SD

335

2.400

1. 298

1.111

0.900

1.800

1.320

Frustration

0.944

0.873

1.

867

1.302

Anger

0.444

0.616

1.

533

1. 457

Anxiety

0.889

0.832

2.067

1.163

Difficulty concentrating

0.611

0.778

1. 667

1.447

E~stl~ssness

l1QOQ

Q1270

~1:2~3

Q.99Q

Nicotine craving

1.

Irritability

611

M

SP
1.
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University
of Nebraska
Medical Center

_

K

800 South •2nd Slttel
Om1ha, NE 63198-2•85
(402) 559·4087

O.p1r1m1nl ol lnl1tn1I Medicine

.

l'vl,,_oty

... ...,, .....

Ind C~Uc11 Cue

4/4/90

!rnest Prentlce, Ph.D.
txecutlve Secretary
In1tltutlonal Review Board
5017 Conkling Hall
UNHC
R!1

IRB 1262-90

Dear Dr. Prentlce,
Thl1 letter l• to lnfor• you that my re1earch entltled "A Co•perlaon
of Smoking Ce11atlon Hethod1 in Normal S•oker1 and Smoker• vlth Chronlc
Ob1tructlve Pul~onery Di1ea1e" ha• been co•pletad. A total of 60 1•oker1
entered the atudy. There vere no co•pllcatloa1.
Slnceuly,
/>1CL'-':r

G.

,~~l.LLL.-.,

'Pt4-·C..

Hary B. Mueller, PA-C
Prlnclpal Inve1tlgator

Unl•111llr of N1b•11,1-Llncofn

Unl•111llyol Nebruh

II Om1h1

Unln•1llr ol N11><uh M1dtc11C.nll•
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